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Figure 1.  Bryophytes and other herbs on sale in a Yunnan, China, market.  The newspaper has the contents of a prescription that is 
under preparation, including Rhodobryum.  Photo courtesy of Eric Harris. 
New Medical Sources 
One of the reasons for exploring biological compounds 
in bryophytes is the potential for medical use.  It's a scary 
thought, but substances we know as pesticides and 
fungicides that discourage insect feeding and bacterial or 
fungal attack are likely to have antibiotic properties that 
could prove useful in treating human disease.  We know 
bryophytes contain numerous potentially useful 
compounds, including oligosaccharides, polysaccharides, 
sugar alcohols, amino acids, fatty acids, aliphatic 
compounds, phenylquinones, and aromatic and phenolic 
substances, but much work remains to link medical effects 
with specific bryophyte species or compounds (Pant & 
Tewari 1990).  For this reason, traditional uses named here 
should be viewed with caution because we don't know the 
dosage needed, side effects, or other precautions that need 
to be taken.  We do know that traditional medicines that 
may be safe for one race of people may not be for others.  
After all, those alive today are descendents of survivors.  
And diet may affect the ways that some of these 
compounds work, causing geographic differences. 
Hansen (1994) suggested that fatty acids produced by 
members of Hypnaceae (Figure 70) and Brachytheciaceae 
(Figure 2) produce high levels of arachidonic acid and EPA 
and might be used for "producing unique and highly priced 
compounds for pharmaceutical industry."  Mosses contain 
both n-3 (EPA, 18:3) and n-6 (arachidonic acid, DHGLA, 
18:2) fatty acids.  Gellerman et al. found that Mnium 
(Figure 3), Polytrichum (Figure 4), and Marchantia 
(Figure 5) have highly unsaturated lipids.  Thus, the 
potential is real – we need to explore it. 
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Figure 2.  Eurhynchium striatum, a member of the 
Brachytheciaceae with a high content of arachidonic acid.  Photo 
by Michael Lüth, with permission. 
 
Figure 3.  Mnium stellare.  The genus Mnium is known to 
have highly unsaturated lipids.  Photo by Michael Lüth, with 
permission. 
 
Figure 4.  Polytrichum commune is used in China to reduce 
inflammation and fever, as well as to treat the common cold and 
kidney and gallstones.  Photo by Michael Lüth, with permission. 
Asakawa has spent his career studying the secondary 
compounds of liverworts.  In this time he has found that 
some of them produce a number of terpenoids, aromatic 
compounds, and acetogenins, several of which show 
interesting biological activity (Asakawa 2008; Asakawa et 
al. 2013).  Among these are agents that cause allergenic 
contact dermatitis, insecticides, insect antifeedants, 
cytotoxins, piscicides, muscle relaxants, plant growth 
regulators, anti-HIV agents, DNA polymerase β inhibitory 
compounds, anti-obesity compounds, neurotrophic agents, 
NO production inhibitors, antimicrobial agents, and 
antifungal agents.  However, few of these have reached 
application by the medical practitioners. 
 
Figure 5.  Marchantia polymorpha thallus illustrating the 
surface that the Chinese considered to resemble the cross section 
of the liver.  Photo by Michael Lüth, with permission. 
Bryophytes can be cultured to produce medical 
compounds.  Using knockout genes, we cannot only 
sequence the genome of bryophytes, but also determine the 
function of individual genes.  It is also easier to transplant 
genes into the bryophyte genome than into tracheophytes.  
This is possible because the bryophyte spends an extended 
period of time as a leafy plant with only one set of 
chromosomes.  The model system Physcomitrella patens 
(Figure 6, Figure 7) is superior to the traditional 
mammalian production hosts and cultures can even be 
stored frozen for ten years, then begin producing again 
when thawed and cultured (Beike et al. 2010). 
 
 
Figure 6.  Physcomitrella patens growing in the wild.  Photo 
by Michael Lüth, with permission. 
 
Figure 7.  Physcomitrella patens growing on agar plates.  
Photo by Sabisteb, through Creative Commons. 
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Herbal Medicines 
Not surprisingly, herbal medicines of China (Figure 1), 
India, and Native Americans include bryophytes (Harris 
2008).  In China, 63 species are known to have medicinal 
uses.  In India, 22 species are known to have medicinal use, 
but only in the Himalayas.  Ayurvedic (holistic medicine of 
India, over 3000 years old) texts report little or no use.  
Native Americans have used bryophytes for drugs, fibers, 
and clothing (University of Michigan, Dearborn, 2003).  
The mosses Calymperes (Figure 8), Campylopus (Figure 
9), and Sphagnum (Figure 10) have been used for 
medicinal purposes in Malaysia (Burkill 1966; Tan 2003).  
Timmiella (Figure 11) has been used medicinally in Egypt 
(Harris 2008). 
 
 
Figure 8.  Calymperes erosum, considered a medicinal plant 
in Malaysia.  Photo by Li Zhang, with permission. 
 
 
Figure 9.  Campylopus introflexus, considered a medicinal 
plant in Malaysia.  Photo by Michael Lüth, with permission. 
Native Americans have long traditions of using 
bryophytes for medical purposes.  The languages of the 
natives of the central coast of British Columbia include 
words for Plagiomnium insigne (Figure 12) that mean tiny, 
tiny little trees in Oweekeno; this moss is important to them 
for medicinal use (Turner 1973; Compton 1993; Harris 
2008).  The users recognize two different forms of the 
species (Compton 1993; Harris 2008).  Those that grow 
under Douglas fir (Pseudotsuga menziesii; Figure 13) are 
less effective medically than those that grow under spruce 
(Picea; Figure 14). 
 
Figure 10.  Sphagnum centrale, considered a medicinal 
plant in Malaysia.  Photo courtesy of Betsy St. Pierre. 
 
 
Figure 11.  Timmiella barbuloides with capsules.  A species 
of Timmiella is used for medicine in Egypt.  Photo by Michael 
Lüth, with permission. 
 
 
Figure 12.  Plagiomnium insigne with capsules, a species 
used by natives in British Columbia, Canada.  Photo from Botany 
Website, UBC, with permission. 
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Figure 13.  Pseudotsuga menziesii forest in snow, habitat for 
Plagiomnium insigne.  Photo by Dave Powell, USDA, through 
Creative Commons. 
 
 
Figure 14.  Picea sitchensis forest floor.  Plagiomnium 
insigne produces more potent medicine in western spruce forests 
compared to those of Douglas fir.  Photo by Henry Hartley, 
through Creative Commons. 
 
The Doctrine of Signatures (based on the concept that 
God provided visual cues through the characteristics of the 
plants), highly developed during the European 
Renaissance, has dictated the use of a variety of 
bryophytes, especially liverworts, in herbal medicine.  For 
example, liverworts resemble the liver, so they have been 
used to treat liver ailments. 
Asakawa (2015) names Bryum argenteum (Figure 47) 
as an antibacterial moss. 
Not only do a number of bryophytes serve as 
medicinal herbs, but Sphagnum (Figure 10) has been used 
to deliver the medicine by using it to make a suppository 
(Stevenson 2012). 
Medicinal Teas 
Johannes Enroth (Bryonet 28 January 2009) visited the 
Yucatan, Mexico, and discovered mosses in use there.  The 
local guide was a "coba-maya" who was familiar with uses 
of plants.  He reported a medical tea made from a moss 
growing on tree trunks.  Enroth collected a bit and 
identified the moss as Sematophyllum adnatum (Figure 
15). 
 
Figure 15.  Sematophyllum adnatum, a moss used to make a 
medicinal tea in the Yucatan of Mexico.  Photo by Bob Klips, 
with permission. 
The moss Rhodobryum (Figure 1) is used to make a 
medicinal tea (Franquemont et al. 1990; Harris 2008), and 
as you will see below, it has tested medicinal properties 
useful for several medical conditions.  Polytrichum 
commune (Figure 4) has been boiled to make a tea for 
treating colds (Gulabani 1974; Beike et al. 2010). 
Liver Ailments 
The most widely known use of bryophytes determined 
by its appearance is that of Marchantia polymorpha 
(Figure 5) to treat liver and other ailments; the surface 
suggests the cross section of liver (Miller & Miller 1979).  
In China, it is still used to treat the jaundice of hepatitis and 
as an external cure to reduce inflammation (Hu 1987) and 
has gained the reputation of cooling and cleansing the liver 
(Bland 1971).  But it has also been used for liver problems 
in Europe (Thieret 1956) and South America (Garcia 
Barriga 1992; Roig y Mesa 1945). 
Based on the Doctrine of Signatures, it is not 
surprising that Marchantia polymorpha (Figure 5) is not 
the only species in that genus to be used to treat liver 
ailments.  In India, M. convoluta is also used (Rao 2009; 
Chandra et al. 2017).  And Marchantia palacea (Figure 
16) is used to treat hepatitis (Sabovljević et al. 2011; 
Chandra et al. 2017). 
 
 
Figure 16.  Marchantia paleacea, a liverwort used to treat 
hepatitis in India.  Photo by Jan-Peter Frahm, with permission. 
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Perhaps there is more wisdom in these ancient 
remedies than at first appears.  Asakawa (2012) found that 
some of the isolated terpenoids from liverworts had anti-
HIV inhibitory properties.  Fissidens nobilis (Figure 48) is 
useful for jaundice (Asakawa 2015). 
Stones 
In the western Himalayans, native people use 
Wiesnerella denudata (Figure 17) to treat gall stones 
(Kumar et al. 2007).  In China, Polytrichum commune 
(Figure 4) is boiled to make a tea that reputedly helps to 
dissolve stones of the kidney and gall bladder (Gulabani 
1974; Chandra et al. 2017).  Asakawa (2015) reported that 
Conocephalum conicum (Figure 18) is useful in treating 
gallstones. 
 
 
Figure 17.  Wiesnerella denudata, a liverwort used to treat 
gall stones in the western Himalayas.  Photo by Jan-Peter Frahm, 
with permission. 
 
 
Figure 18.  Thallose liverwort, Conocephalum conicum, one 
of the thallose liverworts used to treat gallstones, bites, boils, 
burns, cuts, eczema, and wounds.  Photo by Janice Glime. 
Ringworm 
Riccia spp. (Figure 19) were ground to a paste and 
used in the Himalayas to treat ringworm (Tinea spp., a 
fungus; Figure 20) because of the resemblance of the 
growth habit of those liverworts to the rings made by the 
fungus (Shirsat 2008; Chandra et al. 2017).  Recent tests on 
Riccia fluitans (Figure 21) from Florida indicated no 
ability to inhibit growth of bacteria [Pseudomonas 
aeruginosa (Figure 22), Staphylococcus aureus (Figure 
23)] or yeast (Candida albicans; Figure 24) (Pates & 
Madsen 1955).  Might Riccia species do any better with 
ringworm?   
 
Figure 19.  Circular formations of Riccia species, such as 
this Riccia austinii, suggested their use for curing ringworm, 
according to the Doctrine of Signatures.  Photo by Janice Glime. 
 
 
Figure 20.  Tinea (ringworm) on arm.  Photo by Grook Da 
Oger, through Creative Commons. 
 
 
Figure 21.  Riccia fluitans, a floating aquatic liverwort that 
seems to lack antibiotic properties.  Photo by Jan-Peter Frahm, 
with permission. 
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Figure 22.  SEM of Pseudomonas aeruginosa, a bacterial 
species that is not inhibited by Riccia fluitans.  Photo by Janice 
Haney Carr, through Creative Commons. 
 
Figure 23.  SEM of Staphylococcus aureus, a bacterium that 
is not inhibited by Riccia fluitans.  Photo by NIAID, through 
Creative Commons. 
 
Figure 24.  Candida albicans, a yeast species that is inhibited 
by extracts of the liverworts Conocephalum conicum, 
Marchantia polymorpha, and Plagiochasma appendiculatum, 
but not Riccia fluitans.  Photo from Public Health Image Library, 
through public domain. 
Heart, Blood, and Cardiovascular Medicine 
In China, 30-40 species of bryophytes may be found 
on the shelves of the local pharmacist (Ding 1982).  Among 
the more common ones are Rhodobryum giganteum 
(Figure 25, Figure 30) and R. roseum (Figure 26), used to 
treat nervous prostration and cardio-vascular diseases, the 
latter being a use that may have scientific merit (Wu 1982).  
Among these uses is the treatment of hypertension (high 
blood pressure) with R. giganteum (Wu 1977; Pant 1998; 
Asakawa 2007b, 2015; Chandra et al. 2017). 
 
 
Figure 25.  Rhodobryum giganteum, a species widely used 
medicinally in Yunnan, China.  Photo by David Long, with 
permission. 
 
 
Figure 26.  Rhodobryum roseum, a species that is used to 
treat nervous prostration and cardio-vascular diseases in China.  
Photo by Michael Lüth, with permission. 
In 1977, Wu reported the use of Rhodobryum 
giganteum (Figure 25, Figure 30) to cure cardiovascular 
disease in China.  Chinese scientists have attempted to 
demonstrate the basis for the healing powers of some of the 
mosses, including Rhodobryum giganteum, used in ancient 
treatments in China (Ding 1982).  Going directly to the 
peasants in east Szechuan, the staff of the Laboratory of the 
Fourth Medical School in China learned about mosses used 
by the peasants (Wu 1982).  Through clinical research, they 
successfully demonstrated that an ether extract of 
Rhodobryum giganteum, used by these peasants to cure 
angina, contains volatile oils, lactones, and amino acids; 
when given to white mice, the extract actually reduced the 
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oxygen resistance by increasing the rate of flow in the aorta 
by over 30%.  Is it time to replace ACE inhibitors, calcium 
channel blockers, and beta blockers and their side effects?  
The term Hui Xin Cao in Yunnan refers to the medical 
effect of Rhodobryum species, meaning "return-the-heart-
herb" (Harris 2008).  The Chinese use R. roseum (Figure 
26), R. giganteum (Figure 25, Figure 30), and R. 
ontariense (Figure 27).  Unfortunately, the term Hui Xin 
Cao refers to other plants as well (remember that the name 
refers to its use, not its morphology), including the moss 
Pogonatum cirratum (Figure 28) and the shrub Ledum 
(Figure 29).  Members of the genus Rhodobryum are used 
in Yunnan for minor heart problems (Harris & Yang 2009).  
Usage depends on location, not on gender, occupation, or 
ethnicity.  And its use also occurs in both rural areas and in 
traditional Chinese medicine hospitals and medical 
colleges. 
 
 
Figure 27.  Rhodobryum ontariense, a species used in China 
to treat the heart.  Photo by Janice Glime. 
 
 
Figure 28.  Pogonatum cirratum, a species used in China to 
treat the heart.  Photo by Li Zhang, with permission. 
These reports of traditional usage were supported by a 
number of studies on Rhodobryum. giganteum (Figure 25, 
Figure 30) that demonstrated its usefulness in treating 
cardiovascular problems and illustrating the physiological 
mechanisms involved (Yu & Ma 1993; Yu et al. 1994, 
1995; Yan et al. 1998; Lei et al. 2001a, b; Gao et al. 2004; 
Zhou et al. 2004; Wang et al. 2005; Dai et al. 2006; Hu et 
al. 2009).  Pejin et al. (2011a, 2012c) reported on the 
antihypertensive effect of R. ontariense (Figure 27) in vivo 
and attempted to find the mechanism used by R. ontariense 
in controlling hypertension (Pejin et al. 2012e).  They were 
able to eliminate any effect on human erythrocyte 
membrane fluidity, there was no reservoir of nitric oxide in 
the blood, and there was only low ABTS cation scavenging 
activity and little content of phenolic contents.  The actual 
mechanism remains elusive. 
 
 
Figure 29.  Ledum sp., a shrub with the same Chinese name 
as Pogonatum cirratum and several species of Rhodobryum 
because they are all used to treat heart problems.  Photo by 
Meggar, through Creative Commons. 
Masanobu Higuchi (Bryonet, 20 November 2006) 
reports that when he stayed in Zhong Dian, northwestern 
Yunnan, China, in 1994, he saw local people selling herbal 
medicines by the roadside.  Among these was the moss 
Rhodobryum giganteum (Figure 25, Figure 30) in dry 
condition, a traditional Tibetan medicine for heart trouble.  
It was selling for US $0.50 per 10g.  The same species is 
used in the Himalayas as a neurologial and cardiac activant 
(Kumar et al. 2007). 
As already noted, their use as medical plants has made 
Rhodobryum species the subject of a number of 
biochemical studies, revealing a variety of biochemical 
constituents in R. ontariense (Figure 27) [fatty acids 
9,12,15-octadecatrien-6-ynoic and α-linolenic acid, having 
known heart protective activity (Pejin et al. 2012a); 1-
kestose, a "health promoter" (Pejin et al. 2012b ); short-
chain fructooligosaccharides, well known as prebiotics 
(Pejin et al. 2012e).  Thirteen essential oils have been 
identified in R. ontariense (Pejin et al. 2011b), but their 
roles in efficacy of Chinese medicine still remain to be 
determined. 
But wait!  Mosses are known accumulators of heavy 
metals, and we know that high amounts of these are 
dangerous to human health.  Pejin et al. (2012d) tested 
Rhodobryum ontariense (Figure 27) for its heavy metal 
content.  Fortunately, they found that the concentrations of 
arsenic, cadmium, chromium, copper, iron, lead, mercury, 
nickel, manganese, and zinc in these mosses used in tea 
were at safe levels for a typical daily intake of the tea.  
They suggested that manganese was one of the important 
components in treating hypertension.  Nevertheless, these 
results do not mean that the Chinese populations and 
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species are safe as the heavy metal concentrations vary by 
locations and distance from pollution source. 
Lisu women in Yunnan Province, China, hike to fens 
in the alpine area above the Salween River Valley (Nu 
Jiang) to collect large amounts of Sphagnum (Figure 10), 
which they subsequently dry (James Shevock, Bryonet, 16 
January 2007).  Despite about 27 species of Sphagnum 
reported in Yunnan, these Lisu women (one of several 
minority peoples in Yunnan Province) seem able to 
recognize a particular species in the field; they claim that it 
is only this species that is used for medicinal purposes.  
This species of Sphagnum is used as a heart tonic, 
probably brewed like a tea.  Once dried and packaged, the 
moss was to be exported to Canada!  (Surely Canada has 
more Sphagnum than Yunnan?) 
 
 
Figure 30.  Dried Rhodobryum giganteum (left container) at 
a shop in Yunnan, China.  Photo by David Long, with permission. 
In India, bryophytes have also been used to treat heart 
disease.  One such treatment is with Cratoneuron filicinum 
(Figure 31) (Pant 1998; Asakawa 2015; Chandra et al. 
2017). 
 
 
Figure 31.  Cratoneuron filicinum, a species used in India to 
treat the heart.  Photo by Barry Stewart, with permission. 
The Indians have also used several bryophytes to stop 
bleeding.  These include the thallose liverwort Reboulia 
hemisphaerica (Figure 32) and the mosses Funaria 
hygrometrica (Figure 33), Plagiomnium cuspidatum 
(Figure 34), Polytrichum commune (Figure 4), 
Pogonatum cirratum (Figure 28), and Taxiphyllum 
taxirameum (Figure 35) (Gulabani 1974; Ding 1982; Pant 
1998; Asakawa 2007b, 2015; Azuelo et al. 2011; Alam 
2012; Shirsat 2008; Chandra et al. 2017). 
 
Figure 32.  Reboulia hemisphaerica, a species used in India 
to stop bleeding.  Photo by Jan-Peter Frahm, with permission. 
 
 
 
 
 
Figure 33.  Funaria hygrometrica, a species used in India to 
stop bleeding.  Photo by Michael Lüth, with permission. 
 
 
 
 
 
 
Figure 34.  Plagiomnium cuspidatum, a species used in 
India to stop bleeding.  Photo by Hermann Schachner, through 
Creative Commons. 
2-1-10  Chapter 2:  Medical Uses:  Medical Conditions 
 
Figure 35.  Taxiphyllum taxirameum, a species used in India 
to stop bleeding.  Photo by Michael Lüth, with permission. 
Nosebleeds 
One odd choice is the use in Cambridge of 
Homalothecium sericeum (Figure 36) from skulls used to 
treat nosebleeds, with recorded records as early as 1537 
(Belcher & Swale 1998).  The skulls were placed in damp 
places to cultivate this moss.  But other researchers 
concluded that the tale was concocted and that no 
medicinal value was present (Scott 1988).  On the other 
hand, Robert Boyle used it effectively on his own 
nosebleeds.  Perhaps it is just a good absorbent. 
 
 
 
Figure 36.  Homalothecium sericeum from skulls is used to 
treat nosebleeds in Cambridge.  Photo by Michael Lüth, with 
permission. 
In another context, Plagiomnium cuspidatum (Figure 
34) has been used to treat nosebleeds in India (Pant 1998; 
Asakawa 2007a, 2015).  This casts suspicion on my 
suggestion of absorbency as this species does not rehydrate 
easily.  On the other hand, as already noted, Asakawa 
(2015) reported that the mosses Funaria hygrometrica 
(Figure 33), Oreas martiana (Figure 38), Polytrichum 
commune (Figure 4), and Taxiphyllum taxirameum 
(Figure 35) and the liverwort Reboulia hemisphaerica 
(Figure 32) stop bleeding. 
Neurological Conditions 
Few bryophytes seem to be used for neurological 
conditions.  Nevertheless, in Cambridge, England, the moss 
Homalothecium sericeum (Figure 36) from skulls has been 
used in the treatment of epilepsy (Belcher & Swale 1998).  
In China, liverworts have been used to treat convulsions, 
neurasthenia (emotional disturbance typically involving 
lassitude, fatigue, headache, and irritability), and other 
nerve conditions (Asakawa 2012).  Rhodobryum roseum is 
useful for treating neurasthenia (Asakawa 2015). 
Several bryophytes have been used to treat pain.  For 
Leucobryum bowringii (Figure 37), a paste is made of leaf 
tips mixed in a cup of Phoenix sylvestris (silver date palm) 
to treat pain (Lubaina et al. 2014; Chandra et al. 2017).  
Oreas martiana (Figure 38) is used as an anodyne for 
treating pain (Asakawa 2007b, 2015; Chandra et al. 2017).  
These authors also reported the use of Oreas martiana to 
treat nervosism and nervous exhaustion as well as epilepsy.  
Ditrichum pallidum (Figure 39) has been used in India to 
treat convulsions, especially in infants (Pant 1998; 
Asakawa 2007b, 2015; Chandra et al. 2017). 
 
 
Figure 37.  Leucobryum bowringii, a species used to treat 
pain.  Photo through Creative Commons. 
 
 
Figure 38.  Oreas martiana, a species used to treat pain.  
Photo by Michael Lüth, with permission. 
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Figure 39.  Ditrichum pallidum on the forest floor.  This 
species has been used in India to treat convulsions in infants.  
Photo by Janice Glime. 
Inflammation and Fever 
Today we have freezers and use cold packs to soothe 
inflammation and reduce fevers, but not so long ago those 
conveniences were not available.  Instead, Polytrichum 
commune (Figure 4) has been used in China to reduce 
inflammation and fever (Ding 1982; Chandra et al. 2017), 
and the Seminole native people in North America used the 
small mosses Barbula unguiculata (Figure 40) and Bryum 
capillare (Figure 41), as well as larger mosses like 
Octoblepharum albidum (Figure 42), as external 
applications for fever and body aches (Sturtevant 1954; 
Chandra et al. 2017).  Barbula indica (Figure 43) and 
Weissia controversa (Figure 44) have also been used in the 
Western Ghats to treat intermittent fever (Lubaina et al. 
2014).  Taxiphyllum taxirameum (Figure 35) is an anti-
inflammitory (Asakawa 2015). 
 
 
 
Figure 40.  Barbula unguiculata, a moss used by Seminole 
native people in North America to treat body aches and fever.  
Photo by Bob Klips, with permission. 
 
Figure 41.  Bryum capillare with capsules, a moss used by 
Seminole native people in North America to treat body aches and 
fever.  Photo by Michael Lüth, with permission. 
 
 
Figure 42.  Octoblepharum albidum, a moss used by 
Seminole native people in North America to treat body aches and 
fever.  Photo by Niels Klazenga, with permission. 
 
 
Figure 43.  Barbula indica, a moss used in the Western 
Ghats to treat fever.  Photo by Li Zhang, with permission. 
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Figure 44.  Weissia controversa, a moss used in the Western 
Ghats to treat fever.  Photo by Michael Lüth, with permission. 
Fontinalis antipyretica (Figure 45) reputedly got its 
specific name from its ability to work against fever, as 
recorded in the journal of Linnaeus (Nils Cronberg, pers. 
comm.).  Drobnik and Stebel (2014) found that its use 
against fever is reported in pre-Linnaean bryophyte floras 
of central Europe.  However, many people have interpreted 
the name to be derived from its use to insulate chimneys 
against fire, where in actuality it seems to have little value.  
On the other hand, it may reduce the heat penetrating into 
the house.  But does it reduce fever?  Perhaps it can serve 
as a cool poultice. 
  
 
Figure 45.  Fontinalis antipyretica, reported by Linnaeus as 
being used to treat fever.  Photo by Michael Lüth, with 
permission. 
Sabovljević et al. (2011) reported the use of 
Marchantia palacea (Figure 16) to reduce swelling and 
bring down fever.  Leptodictyum riparium (Figure 46), an 
aquatic moss, Philonotis fontana (Figure 62), a wetland 
moss, and the cosmopolitan moss Bryum argenteum 
(Figure 47) are used to treat fever in India (Pant 1998; 
Asakawa 2007b, 2015; Chandra et al. 2017).  
Octoblepharum albidum (Figure 42) was considered in 
India to have similar ability to reduce fever (Singh 2011; 
Chandra et al. 2017).  The mosses Haplocladium 
capillatum (see Figure 52) and Leptodictyum riparium, 
Polytrichum commune (Figure 4), Rhodobryum 
giganteum (Figure 25, Figure 30), and Weissia controversa 
(Figure 44) and the thallose liverworts Conocephalum 
conicum (Figure 18) and Marchantia polymorpha (Figure 
5) are likewise antifever agents. 
 
 
 
Figure 46.  Leptodictyum riparium, a moss used to treat 
fever in India.  Photo by David T. Holyoak, with permission. 
 
 
Figure 47.  Bryum argenteum, a moss used to treat fever in 
India.  Photo by Tushar Wankhede, through Creative Commons. 
Urinary and Bowel Treatments 
The Chinese also use Polytrichum commune (Figure 
4) as a detergent diuretic, laxative, and hemostatic agent 
(Ding 1982; Ando & Matsuo 1984; Hu 1987; Fan et al. 
2004; Harris 2008).  In India, Fissidens nobilis (Figure 48) 
and Dawsonia longifolia (Figure 49) are used as diuretics 
(Pant 1998; Azuelo et al 2011; Chandra et al. 2017), and 
Asakawa (2015) reports Marchantia polymorpha (Figure 
5) for the same purpose.  Pogonatum cirratum (Figure 28) 
has been used as a laxative in India (Azuelo et al. 2011; 
Alam 2012; Chandra et al. 2017).  Asakawa (2015) reports 
Fissidens nobilis (Figure 48) as a diuretic and 
Haplocladium capillatum (see Figure 52) for treatig 
cystitis and uropathy.  Leptodictyum riparium (Figure 46) 
and Rhodobryum giganteum (Figure 25, Figure 30) 
likewise are used to treat uropathy (restricted urine flow) 
(Asakawa 2015). 
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Figure 48.  Fissidens nobilis, a species that is used as a 
diuretic in India.  Photo by Jan-Peter Frahm, with permission. 
 
 
Figure 49.  Dawsonia longifolia, a species used as a diuretic 
in India.  Photo by Jan-Peter Frahm, with permission. 
I was surprised to find Polytrichum juniperinum 
(Figure 50) listed in Materia Medica as a treatment for 
painful urination of the elderly, obstruction or suppression, 
and dropsy (Available Materia Medicas 2011).  The 
medicine is made by boiling two ounces of the moss in a 
liter of water until it boils down to only half that – a pint, 
making a "tincture."  One dose (4 ozs, 113 g) should be 
taken every 8 hours. 
 
 
Figure 50.  Polytrichum juniperinum, a hairy cap moss, is 
used in China to treat urinary and prostate problems.  It can be 
recognized by the brown tips on the leaves and the rolled over leaf 
edges that cover the lamellae.  Photo by Michael Lüth, with 
permission. 
The leafy liverwort Herbertus sp. (Figure 51) is used 
in India as an antiseptic, antidiarrheal agent, expectorant, 
and astringent (Azuelo et al. 2011; Alam 2012; Chandra et 
al. 2017).  In both China and India, cystitis (inflammation 
of the bladder) has been treated with the moss 
Haplocladium microphyllum (Figure 52) (Ding 1982; Pant 
1998). 
 
 
Figure 51.  The leafy liverwort Herbertus sendtneri.  Some 
members of the genus Herbertus are used in India as a filter for 
smoking.  Photo by Michael Lüth, with permission. 
 
Figure 52.  Haplocladium microphyllum, a species that is 
used to treat bladder infections in China and India.  Photo by 
Robin Bovey, with permission through Dale Vitt. 
Gynecology 
The absorbent properties that make Sphagnum (Figure 
10) an excellent bandage also make it suitable for diapers 
and sanitary napkins, a product currently sold by Johnson 
and Johnson Company (D. H. Vitt, pers. comm.). 
 
 
Figure 53.  Sphagnum Sanitary napkin.  Photo from National 
Museum of American History, with online permission. 
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Sphagnum (Figure 10) has also been used, along with 
grass, sponge, and other plant fiber, as a contraceptive to 
block the entry of sperm (Stanley 1995).  By contrast, 
following successful pregnancies, the Nitinaht peoples of 
Vancouver Island, Canada, used Polytrichum commune 
(Figure 4) as a gynecological aid (Turner et al. 1983; 
Chandra et al. 2017).  Women in labor chewed the moss to 
speed up the labor process. 
In China, Polytrichum (Figure 4, Figure 50) has been 
used to stop bleeding and night sweats, presumably 
associated with menopause (EBCHSATCM 1999; Cheng et 
al. 2008; Fu et al. 2009).  It has also been used to treat 
uterine prolapse (the uterus sags due to weakening of 
muscles or ligaments that support it). 
The moss Oreas martiana (Figure 38) is used to treat 
menorrhagia (prolonged bleeding with menstrual period) 
(Asakawa 2007b; Chandra et al. 2017).  Barbula indica 
(Figure 43) has been used in the Western Ghats to treat 
menstrual pain (Lubaina et al. 2014; Chandra et al. 2017). 
Disinfectant and Infections 
The Native American Nitinahts also used Sphagnum 
(Figure 10) as a disinfectant (Turner et al. 1983).  
Fissidens (Figure 54) is used in China as an antibacterial 
agent for swollen throats and other symptoms of bacterial 
infection, and in Bolivia it likewise has medicinal uses.  
Judith Sullivan (Bryonet, 16 January 2007) reported seeing 
labels on Chinese medicines that included Grimmia (Figure 
55), Atrichum (Figure 56), Polytrichum (Figure 4, Figure 
50), and Thuidium (Figure 57), primarily as anti-bacterial 
and anti-inflammatory agents.  Polytrichum juniperinum 
(Figure 50) is used there for some prostate and urinary 
difficulties.   
 
 
Figure 54.  Fissidens osmundoides, a moss in one genus 
used as an antibacterial agent to treat sore throats in Bolivia and 
several Asian countries.  Photo by Michael Lüth, with permission. 
 
Figure 55.  Grimmia pilifera, a Chinese species.  Some 
members of this genus are used in medicines in China.  Photo by 
Henk Greven, with permission. 
 
Figure 56.  Atrichum undulatum.  Some members of this 
genus are used in medicines in China.  Photo by Michael Lüth, 
with permission. 
 
 
Figure 57.  Thuidium recognitum.  Some members of 
Thuidium are used as anti-bacterial and anti-inflammatory agents 
in China.  Photo by Jan-Peter Frahm, with permission. 
Dried Sphagnum (Figure 58) is sold to treat 
hemorrhages (Bland 1971), and S. teres (Figure 58) is used 
to treat eye diseases and hemorrhoids (Ding 1982).  
Haplocladium microphyllum (Figure 52) is sold to treat 
bronchitis, tonsillitis, and tympanitis, as well as cystitis 
(Ding 1982). 
 
 
Figure 58.  Sphagnum teres is used to treat eye diseases in 
Asia.  Photo by Michael Lüth, with permission. 
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As noted in Chapter 1 of this volume, the soap 
Sphagnol is a Sphagnum (Figure 10; Figure 58) product 
used to treat skin problems such as acne, eczema, chilblains 
(painful inflammation of small blood vessels in the skin), 
dandruff, insect bites, and ringworm (a fungus) (The 
Science Museum 2012).  This product was used during 
both World Wars by the British Red Cross to treat facial 
wounds and is believed to have antibiotic properties. 
Kumar et al. (2007) reported on antibacterial species 
used in India, as discussed in Chapter 2-2 on Biologically 
Active Substances.  Oreas martiana (Figure 38) and 
Taxiphyllum taxirameum (Figure 35) likewise are used to 
treat wounds (Asakawa 2015), perhaps having antibiotic 
properties.  the leafy liverwort Frullania tamarisci has 
known antiseptic properties (Asakawa 2015). 
Nose and Throat 
In both India and North America, the moss Philonotis 
fontana (Figure 62) has been used to treat 
adenopharyngitis, an inflammation of the pharynx and 
tonsils (Flowers 1957; Pant 1998; Asakawa 2007b; 
Chandra et al. 2017).  Haplocladium capillatum (see 
Figure 52) and Philonotis fontana likewise can be used to 
treat adenopharyngitis (Asakawa 2015).  Bryum 
argenteum (Figure 47) and Weissia controversa (Figure 
44) have chemical properties used to treat rhinitis 
(inflammation of the mucous membrane of the nose) 
(Asakawa 2015). 
Lung Diseases 
Funaria hygrometrica (Figure 33) has been used in 
India to treat pulmonary tuberculosis (Pant 1998; Chandra 
et al. 2017), and Asakawa (2015) indicates it has 
compounds useful for that purpose, as does Polytrichum 
commune (Figure 4).  The similarity of Marchantia 
polymorpha (Figure 5) thalli to the texture of lung tissue 
caused Europeans to use that liverwort to treat pulmonary 
tuberculosis (Bland 1971).  It is likely that this Doctrine of 
Signatures was also responsible for the Chinese use of 
liverworts to treat pulmonary tuberculosis (Asakawa 2012).  
It is interesting that its thallus has been interpreted as 
resembling both liver tissue and lung tissue. 
In Cambridge, England, the moss Homalothecium 
sericeum (Figure 36) was used to treat whooping cough 
(Belcher & Swale 1998).  In the Himalayas the moss 
Haplocladium microphyllum (Figure 52) is used to treat 
bronchitis (Kumar et al. 2007).  Haplocladium 
microphyllum has also been used to treat tonsillitis and 
pneumonia (Ding 1982; Pant 1998; Chandra et al. 2017); 
H. capillatum (see Figure 52) is known for its use in 
treating in pneumonia (Asakawa 2015). 
Treatments of colds, not surprisingly, has made use of 
bryophytes.  Hyophila involuta (Figure 59) has been used 
for the symptoms of a cold, cough, and sore throat.  This 
treatment is a leaf decoction with a pinch of ground pepper, 
used daily (Lubaina et al. 2014; Chandra et al. 2017).  Also 
in India, natives in the Western Ghats have used Weissia 
controversa (Figure 44)  to treat colds. 
 
Figure 59.  Hyophila involuta drying.  This species has been 
used to treat cold, cough, and sore throat.  Photo by Bob Klips, 
with permission. 
The other side of the coin is the ability of some 
mosses, especially Sphagnum (Figure 58), to harbor fungi 
that cause lung disease.  Sphagnum was once thought to 
harbor Mycobacteria (Figure 60), the genus in which the 
tuberculosis bacterium resides, but now it seems that it is 
not the reservoir for this genus it was thought to be (Deriu 
et al. 1995).  On the other hand, the fungus Sporothrix 
schenckii (Figure 61), common on Sphagnum, does cause 
pulmonary sporotrichosis, an infection of the lung 
resulting from breathing the fungi (McCain & Buell 1968). 
 
 
Figure 60.  Mycobacterium tuberculosis SEM, member of a 
pathogenic genus once thought to live among Sphagnum.  Photo 
from NIAID, through Creative Commons. 
 
Figure 61.  Sporothrix schenckii conidia, a species that 
grows among Sphagnum and causes sporotrichosis.  Photo from  
USDHHS, through public domain. 
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Skin Ailments and Burns 
The antibiotic properties of many bryophytes suggest 
that they should promote healing of skin infections.  The 
thallose liverwort Reboulia hemisphaerica (Figure 32) is 
used to treat skin blotches, external wounds, and bruises 
and Oreas martiana (Figure 38) is used to treat external 
wounds (Asakawa 2007b, 2015; Chandra et al. 2017).  
Fissidens nobilis, Conocephalum conicum (Figure 18), 
and Marchantia polymorpha (Figure 5) have compounds 
that help in the healing of burns (Asakawa 2015).  Funaria 
hygrometrica (Figure 33) is useful in treating bruises and 
Athlete's foot.  Rhodobryum giganteum (Figure 25, Figure 
30), Conocephalum conicum, and Marchantia 
polymorpha can be used to treat cuts (Asakawa 2015). 
Himalayan Indians use a mixture of moss ashes with 
fat and honey to soothe and heal cuts, burns, and wounds 
(Pant et al. 1986; Pant 1998; Chandra et al. 2017), claiming 
that these ashes heal wounds more quickly (Pant & Tewari 
1989).  Taxiphyllum taxirameum (Figure 35) is among 
those mosses used to treat surface wounds (Pant 1998; 
Asakawa 2007b; Chandra et al. 2017).  In the Himalayas, 
the Gaddi tribe uses Philonotis fontana (Figure 62) and 
Plagiochasma appendiculatum (Figure 63) to treat burns 
and skin diseases (Flowers 1957; Pant 1998; Asakawa 
2007b; Kumar et al. 2007; Shirsat 2008; Alam 2012; 
Chandra et al. 2017).  Bryum thomsonii is used in the 
Northwest Himalayas for healing wounds (Kumar et al. 
2007).  Himalayan Indians have used Marchantia 
polymorpha (Figure 5; Figure 64) or M. palmata to treat 
boils and abscesses because the young archegoniophore 
resembles a boil as it emerges from the thallus (Pant & 
Tewari 1989). 
 
 
Figure 62.  Philonotis fontana is a wetland moss used by 
Gosuite native people to relieve pain of burns.  Photo by Michael 
Lüth, with permission. 
In India, the pendent moss Aerobryum lanosum is 
used to treat burns.  The whole plant is boiled in goat urine 
and applied externally (Lubaina et al. 2014; Chandra et al. 
2017).  Species of Mnium (sensu lato?) (Figure 3) have 
been used in a poultice to reduce pain from bruises, 
wounds, and burns (Azuelo et al. 2011; Chandra et al. 
2017).   Similarly, these authors found that Plagiomnium 
(Figure 12, Figure 34) has been used for treating infections 
and swellings. 
Also in India, the thallose liverwort Targionia 
hypophylla (Figure 65) is used, mixed with leaves of the 
flowering plant Actiniopteris radiata, and ground into a 
paste, then mixed with two tablespoons of coconut oil.  
This paste is smeared over the body of the children affected 
by itching skin, scabies, and other skin diseases (Remesh & 
Manju 2009; Chandra et al. 2017). 
 
 
Figure 63.  Plagiochasma appendiculatum with 
archegoniophores, a species used in the Himalayas to treat burns 
and skin diseases.  Photo by Michael Lüth, with permission. 
 
 
Figure 64.  Young archegoniophores of Marchantia 
polymorpha, somewhat resembling a boil.  Photo by Rudolf 
Macek, with permission. 
 
 
Figure 65.  Targionia hypophylla, a species used in India to 
treat skin diseases.  Photo by Martin Hutten, with permission. 
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Marchantia palmata is made into a fleshy leaf paste 
and applied directly to acute inflammation caused by heat 
(burns) (Tag et al. 2007; Chandra et al. 2017). 
Another skin-related use in India is that of the 
cosmopolitan moss Funaria hygrometrica (Figure 33) to 
treat bruises and skin infections (Pant 1998; Chandra et al. 
2017). 
Among the Native Americans, the Cheyenne in 
Montana use Polytrichum juniperinum (Figure 50) in 
medicines (Hart 1981).  In Utah, USA, the Gosuite native 
peoples used Bryum (Figure 41, Figure 47), Mnium 
(Figure 3), Philonotis (Figure 62), and various matted 
hypnaceous forms crushed into a paste applied to reduce 
the pain of burns,  bruises, and wounds (Flowers 1957).  
Sphagnum (Figure 10) was used by Native Americans as a 
carrier for berries that were rubbed on children's sores 
(Carrier Linguistic Committee 1973). 
As one might expect, the Chinese have used liverworts 
in the treatment of skin ailments, including cuts, burns, and 
bruises (Asakawa 2012).  A mixture of the thallose 
liverworts Conocephalum conicum (Figure 18) and 
Marchantia polymorpha (Figure 5) with vegetable oils is 
used in China on bites, boils, burns, cuts, eczema, and 
wounds (Wu 1977; Ding 1982; Ando 1983; Yan et al. 
1999). 
In China and India, Conocephalum conicum (Figure 
18) has a number of medical uses.  Its antimicrobial, 
antifungal, antipyretic, and antidotal activities contribute to 
its usefulness to treat cuts, swollen tissue, scalds, burns, 
fractures, and poisonous snake bites (Ding 1982; Alam 
2012; Chandra et al. 2017).  Likewise, Marchantia 
polymorpha (Figure 5) has been used to treat snake bites 
(Hu 1987; Shirsat 2008; Azuelo et al. 2011; Asakawa 
2015; Chandra et al. 2017).  Bryum argenteum (Figure 
47), Polytrichum commune (Figure 4), and one or more 
species of Philonotis (Figure 62) have been used as 
antidotes (Asakawa 2007b, 2015; Chandra et al. 2017). 
Alaskan native peoples have used Sphagnum (Figure 
10), mixed with fat, to make a salve (Schofield 1969; 
Miller & Miller 1979).  In Britain Sphagnum was used to 
treat boils (Bland 1971), its derivative sphagnol to relieve 
the itch of a mosquito bite (Crum 1988), and for medicinal 
baths (Crum 1973; Weber & Ploetner 1976; Turner 1993), 
although the small amounts of active substances put into an 
average bath are not likely to have any effect.   
Nevertheless, Mitchell and Rook (1979) caution us 
about the possible allergenic effects of Sphagnum (Figure 
10), especially because of its ability to harbor the fungus 
causing sporotrichosis (Adams et al. 1982).  It is a known 
danger to nursery workers and harvesters who are in 
constant contact with the Sphagnum (D'Alessio et al. 
1965; McCain & Buell 1968; Tamblyn 1981; Keller 1988; 
Padhye & Ajello 1990; Coles et al. 1992), even affecting 
areas like the abdomen (Frankel & Frankel 1982).  In 1988, 
sporotrichosis reached sufficient proportions that 
"Sphagnum the culprit" made its debut in the Milwaukee 
Journal (Rosenberg 1988).  In 1995, nine of the 65 workers 
involved in making topiary art at a Florida nursery became 
infected with lymphocutaneous sporotrichosis (Hajjeh et al 
1997).  Even forestry workers who don't handle the moss 
directly can contract the disease from working in peatlands 
(Powell et al. 1978).  The threat is sufficient to cause the 
American Orchid Society to warn its members of this 
occupational hazard (Padhye & Ajello 1990).  The 
Macauley Institute in Aberdeen, England, is investigating 
the use of hydroponics to produce Sphagnum that is free of 
microorganisms and other contaminants.  Wearing gloves 
helps to protect against the lymphocutaneous sporotrichosis 
(Hajjeh et al. 1997), but longer exposures can still lead to 
pulmonary infections. 
Eye Problems and Diseases 
In the northwest Himalayas, Sphagnum teres (Figure 
58) is used to treat ophthalmic diseases (Kumar et al. 
2007).  There seems to be medical evidence that at least 
some of the bryophytes can be used effectively to treat age-
related blindness (age-related macular degeneration) 
(Albert-Ludwigs-Universität Freiburg 2010).  Factor H is 
necessary to maintain healthy eyes (Coffey 2007).  The 
Freiburg research lab has produced a protein in a bioreactor 
using factor H from mosses.  Factor H is otherwise known 
only from blood and is important for the immune system.  
50 million people suffer blindness due to lack of this 
protein, especially in industrial countries. 
Büttner‐Mainik et al. (2011) developed a protocol to 
produce Factor H using Physcomitrella patens (Figure 6, 
Figure 7).  Factor H is a protein that is difficult to produce 
in animal lines, but these researchers successfully produced 
it in transgenic P. patens.   
Flatbergium sericeum (Figure 66), a relative of 
Sphagnum, has been used to treat eye diseases (Azuelo et 
al. 2011; Chandra et al. 2017).  Similarly, Sphagnum teres 
(Figure 58) has been used for this purpose in China (Ding 
1982). 
 
 
Figure 66.  Flatbergium sericeum, a species that has been 
used to treat eye diseases.  Photo courtesy of Jon Shaw. 
Ear Ache and Hearing Problems 
Entodon flavescens is used by the Kani tribes in the 
Western Ghats for treating ear ache (Lubaina et al. 2014; 
Chandra et al. 2017).  They use a leaf juice as ear drops, 
especially in cold weather.  Haplocladium capillatum (see 
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Figure 52) has been used to treat tinnitis, but recent news 
reports suggest this is not really related to the ears. 
Hair Treatments 
Soothing a wound of a different sort (human pride), the 
Chinese use Fissidens (Figure 54; Figure 79), burned, to 
put on their heads to encourage hair growth! (Harris 2002).  
In India, Fissidens nobilis (Figure 48) has likewise been 
used to grow hair (Pant 1998; Azuelo et al. 2011).  And 
Asakawa (2015) found compounds in Fissidens nobilis 
(Figure 48) that should promote hair growth 
Most likely following the Doctrine of Signatures, 
Himalayan natives use Polytrichum commune (Figure 4) 
to promote hair growth (Kumar et al. 2007).  The Doctrine 
of Signatures is a theory that the plant tells us what it is 
useful for by its morphology or other properties.  Since 
Polytrichum commune has a hairy calyptra (Figure 67), 
that would suggest it is good for growing hair.  Similarly, 
the hairs on the calyptra most likely account for the use of 
Dawsonia longifolia (Figure 69) to grow hair (Azuelo et 
al. 2011; Chandra et al. 2017). 
 
 
Figure 67.  Polytrichum commune capsules with hairy 
calyptrae (and one with calyptra removed).  This species is used 
to help grow hair.  Photo by Michael Lüth, with permission. 
Frullania ericoides (Figure 68) is used to treat the hair 
and scalp in India (Remesh & Manju 2009; Chandra et al. 
2017).  It purportedly gets rid of head lice and nourishes 
the hair. 
 
 
Figure 68.  Frullania ericoides, a species used in India to 
treat the hair and scalp.  Photo by Paul Davison, with permission. 
 
Figure 69.  Dawsonia longifolia with capsule, showing long 
hairs on the calyptra.  Photo by Vita Plasek, with permission. 
Sedatives 
The use of bryophytes as sedatives seems to be 
uncommon.  The moss Hypnum (Figure 70) was named for 
sleep, but that is because it was used to stuff pillows, not 
for any known sedative effect (Dillenius 1741).  However, 
Plagiopus oederianus (Figure 71) has been used in India as 
a sedative, as well as for treating epilepsy (Pant 1998; 
Asakawa 2015; Chandra et al. 2017).  And the widely used 
Rhodobryum roseum and R. giganteum (Figure 26) 
likewise have been used as sedatives (Wu 1977; Pant 1998; 
Asakawa 2007b, 2015; Chandra et al. 2017). 
 
 
Figure 70.  Hypnum cupressiforme, a moss that filters 
substances out of items for smoking and is used to stuff pillows.  
Photo by Michael Lüth, with permission. 
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Figure 71.  Plagiopus oederianus, a species used in India as 
a sedative and to treat epilepsy.  Photo by Michael Lüth, with 
permission. 
Antidotes 
The mosses Bryum argenteum (Figure 47), 
Haplocladium capillatum (see Figure 52). Philonotis 
fontana (Figure 62), Polytrichum commune (Figure 4), 
and Weissia controversa (Figure 44) can be used as an 
antidote, as well as Conocephalum conicum (Figure 18) 
and Marchantia polymorpha (Figure 5).  But Asakawa 
does not state what things these will treat (Asakawa 2015).  
For Conocephalum conicum, Asakawa reports that it can 
be used to treat snake bites. 
Filters 
Kumaun Indians (also Kumaon) of the Himalayas use 
slender bryophytes such as Herbertus (Figure 51), 
Anomodon (Figure 72), Entodon (Figure 76), Hypnum 
(Figure 70), Meteoriopsis (Figure 73), and Scapania 
(Figure 74), wrapped in a cone of Rhododendron 
campanulatum (Figure 75) leaves, to serve as a filter for 
smoking (Pant & Tewari 1989).  One must wonder if any 
of those heated phenolic compounds in bryophytes might 
be as harmful as the substances they filter out! 
 
 
 
 
Figure 72.  Anomodon rugelii, a moss of vertical surfaces, 
filters substances out of items for smoking.  Photo by Michael 
Lüth, with permission. 
 
Figure 73.  Meteoriopsis squarrosa, a pendent species in the 
Western Ghats.  The genus Meteoriopsis is used as a smoking 
filter in the Himalayas.  Photo by M. C. Nair, K. P. Rajesh, and P. 
V. Madhusoodanan, through Creative Commons. 
 
 
Figure 74.  Scapania gracilis.  Members of this genus are 
used as smoking filters in the Himalayas.  Photo by Michael Lüth, 
with permission. 
 
 
Figure 75.  Rhododendron campanulatum.  Leaves of this 
species are used to wrap bryophytes to serve as smoking filters.  
Photo by Kurt Stüber, through Creative Commons. 
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One peat product has actually entered modern 
medicine as a means to cleanse the body of pollutants:  
humic acids.  HUMET-R syrup entered medicine as a 
transporter of trace elements, reducing excess trace 
elements that are bombarding the human body from 
pollutants and other sources (Kleb et al. 1999).  The active 
substance is humin acid. 
 
 
Figure 76.  The pleurocarpous moss Entodon concinnus is 
used as a smoking filter.  Photo by Michael Lüth, with 
permission. 
Surgical and Larger Wounds 
Bryophytes have been used both in treating and in 
cushioning wounds.  In Utah, the Gosuite native people 
used poultices of Bryum (Figure 41, Figure 47), Mnium 
(Figure 3), Philonotis (Figure 62), and various matted 
hypnaceous forms as padding under splints to set broken 
bones.   
But it is Sphagnum (Figure 10) that has gained fame 
for its use as a bandage (Figure 77) (Painter 2003).  It 
appears that even before the First World War, Sphagnum 
was used to bandage the wounded in the Russo-Japanese 
War (1904-05).  In the First World War, the Americans 
(USA) and Canadians used Sphagnum (peat moss) to make 
bandages, conserving the valuable cotton for making and 
packing gunpowder (Porter 1917; Hotson 1918, 1919, 
1921; Nichols 1918a, b, c, d, 1920).  The wounds 
apparently healed better than those with sterile surgical 
bandages, benefitting from the moisture and fewer 
infections.  The British Army used about 1,000,000 pounds 
(453590 kg) of dressing per month (Nichols 1918c, 1920), 
saving about US $200,000 (Bland 1971), the Canadian Red 
Cross about 200,000 pounds (90720 kg) per month, and the 
United States about 500,000 pounds (226800 kg) during the 
last six months of war (Bland 1971).  After the war, these 
countries returned to traditional gauze bandages, but the 
Chinese have continued to use Sphagnum for this purpose 
(Ding 1982). 
The superiority of Sphagnum (Figure 10) bandages is 
attributed in part to its ability to absorb 3-4 times as much 
liquid as a cotton bandage at a rate three times as fast 
(Porter 1917).  This is due to the interlaced hyaline cells 
that are dead and possess pores (Figure 78).  These cells 
retain water and readily absorb water when dry.  Hence, the 
bandage retains liquids longer and more uniformly, 
necessitating less frequent change.  It is more comfortable 
for the user because it is cooler, softer, less irritating, and 
retards bacterial growth (Banerjee 1974).  In fact, tests 
indicate that the amount of wound area covered by new 
epidermis doubles with use of Sphagnum dressing 
compared to no dressing (Varley & Barnett 1987). 
 
 
Figure 77.  Sphagnum for surgical dressings.  Photo from 
National Museum of American History, with online permission. 
This news article appeared on page 4 of The Seattle 
Star (Washington, USA), 3 April 1918: 
 
???????????????? ??????????? ???? ?????????
Fifty thousand sphagnum dressings, for use in France, 
will be made at the University of Washington before June 
15.  The dressings will follow a new design and will be 
submitted for experiment.  If successful, it is expected that 
a call will come for 50,000 each week. 
Between 800 and 900 freshman and sophomore girls 
are now registered for work on sphagnum moss dressings. 
  
 
Figure 78.  Stained cells of Sphagnum showing large hyaline 
cells with pores and small photosynthetic cells.  Photo and 
drawings by Janice Glime. 
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The pectin complex in the Sphagnum (Figure 78) cell 
wall is similar structurally to immunostimulatory pectin 
from tracheophytes that has traditionally been used for 
healing wounds (Painter 2003). 
Sphagnum (Figure 10) is not the only moss that has 
been used for bandages.  The Nitinaht native people of 
Vancouver Island, Canada, used a moss known as 
maidenhair moss (Fissidens adianthoides; Figure 79) to 
bandage wounds.  The Anglo-Saxons gave it the name of 
maidenhair moss because to them it resembled a maiden's 
pubic hair. 
 
 
Figure 79.  Fissidens adianthoides is the maidenhair moss 
used by the Nitinaht native people for bandages.  Photo by 
Michael Lüth, with permission. 
Perhaps one of the more unusual uses of liverworts is 
the Chinese use to promote healing of fractures (Asakawa 
2012); he reports Conocephalum conicum (Figure 18) and 
Marchantia polymorpha (Figure 5) to be useful for this 
(Asakawa 2015).  Lubaina et al. (2014) reported the use of 
the leafy liverwort Plagiochila beddomei (see Figure 80) 
for healing wounds in the Western Ghats. 
 
 
Figure 80.  Plagiochila sp.  Plagiochila beddomei is used in 
the Western Ghats for healing wounds.  Photo by Lin Kyan, with 
permission. 
The use of Sphagnum (Figure 10) as a bandage is not 
without its hazards, as mentioned earlier.  Perhaps other 
mosses may serve an absorptive function as well or better 
than Sphagnum and impose fewer hazards.  Horikawa 
(1952) compared a number of mosses and their ability to 
absorb water.  He found several that could rival Sphagnum 
in absorptive ability (Table 1). 
 
Table 1.  Weight gain measured as wet weight to dry weight 
ratio of selected bryophytes (Horikawa 1952). 
 
Atrichum 6.9  Figure 56 
Barbula 8.3 Figure 40, Figure 43 
Bazzania pompeana 4.0 cf. Figure 81 
Haplomitrium mnioides 12.0 Figure 82 
Loeskeobryum cavifolium 9.8 cf. Figure 83 
Plagiomnium maximoviczii 6.7 Figure 84 
Rhodobryum 10.0 Figure 25 
Sphagnum 12.4 Figure 58 
Trachycystis microphylla 3.2 Figure 85  
 
 
 
Figure 81.  Bazzania trilobata.  Bazzania pompeana gains 
water up to 4 time its dry weight.  Photo by Janice Glime. 
 
 
Figure 82.  Haplomitrium mnioides, a species that gains 
water up to 12 times its dry weight.  Photo by Yang, Jia-Dong, 
through Creative Commons. 
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Figure 83.  Loeskeobryum brevirostre.  Loeskeobryum 
cavifolium gains water up to 9.8 times its dry weight.  Photo by 
Bob Klips, with permission. 
 
 
Figure 84.  Plagiomnium maximoviczii, a species that gains 
water up to 6.7 times its dry weight.  Photo through Creative 
Commons. 
 
 
Figure 85.  Trachycystis microphylla, a species that gains 
water up to 3.2 times its dry weight.  Photo by Li Zhang, with 
permission. 
Breaking News 
After "completing" the revision of this chapter, I 
received an email announcing the completion of a safety 
study for the pharmaceutical use of a bryophyte-produced 
compound, Moss-aGal (Kirstein 2017).  Six patients were 
monitored for 28 days following a single dose of the 
pharmaceutical and showed no negative effects.  This is 
only phase 1 of the study, but it provides promise in 
relieving symptoms in patients suffering from Fabry 
disease.  This is the first moss-based clinical product to be 
tested in humans.  The research has been done at 
Greenovation, a privately-owned biopharmaceutical 
company based in Heilbronn, Germany.  It was founded in 
1999 by Prof. Dr. Ralf Reski and Prof. Dr. Gunter 
Neuhaus. 
Fabry disease is a rare genetic disease causing a 
deficiency of the enzyme alpha-galactosidase A (a-Gal 
A), hence the name Moss-aGal for the moss compound to 
treat it.  This disease causes a buildup of a type of fat called 
globotriaosylceramide (Gb3, or GL-3) in the body.  Fabry 
disease is classified as a type of lysosomal storage disorder.  
There is no known cure, only treatments of the deficiency. 
 
  
Summary 
Bryophytes have been traditionally used for their 
medicinal properties in China, India, and among Native 
Americans.  Their use in Europe became more 
widespread following the development of the Doctrine 
of Signatures.  Among the most commonly used, 
Marchantia polymorpha was used for liver ailments 
and is still used in some places, but is also used for 
boils and abscesses.  Rhodobryum giganteum is used 
for cardiovascular problems, a use supported by clinical 
tests. 
Traditional uses of bryophytes include treatment 
for liver ailments, ringworm, heart problems, 
inflammation, fever, urinary and digestive problems, 
female problems, infections, lung disease, skin 
problems, and as filters and cleansing agents against 
pollutants. 
The ability of Sphagnum to promote healing of 
flesh wounds is well documented.  Sphagnol is used to 
treat boils and mosquito bites, and Sphagnum in 
diapers prevents diaper rash.  
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Figure 1.  Bryophytes and other herbs on sale in a Yunnan, China, market.  Rhodobryum giganteum (upper bag) and Leucobryum 
(lower bag), both called Hui Xin Cao.  Photo by courtesy of Eric Harris. 
Antibiotics and Other Biologically Active Substances 
Bryophyte species actually produce broad-range 
antibiotics (Asakawa 2007a, b, 2008; Asakawa et al. 2013).  
Their usage in surgical dressings, diapers, and other human 
medicinal applications is well known.  And their use has 
not been confined to Asia (Frahm 2004), but is known in 
Brazil (Pinheiro da Silva et al. 1989), England (Wren 
1956), North America (Pejin et al. 2011a, b), and Germany 
(Frahm 2004), as well as in China (Ding 1982; Wu 1982) 
and India (Watts 1891).  Frahm (2007) has reviewed the 
literature on bryophytes and their antibiotic activity. 
Bryophytes discourage the feeding by a variety of 
organisms, as discussed in the chapters on terrestrial 
insects, arthropods, and other interaction chapters.  Frahm 
and Kirchhoff (2002) showed that extracts of the epiphytic 
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moss Neckera crispa (Figure 2) and leafy liverwort Porella 
obtusata (Figure 3) both discouraged feeding by the 
Portuguese slug Arion lusitanicus (Figure 4). 
 
 
Figure 2.  Neckera crispa, a species that discourages the 
Portuguese slug from eating it.  Photo by Jan-Peter Frahm, with 
permission. 
 
Figure 3.  Porella obtusata, a species that discourages the 
Portuguese slug from eating it.  Photo by Michael Lüth, with 
permission. 
 
Figure 4.  Arion lusitanicus, a slug that avoids eating 
extracts of the moss Neckera crispa and leafy liverwort Porella 
obtusata.  Photo by Ondřej Zicha, through Creative Commons. 
One indication of the presence of unique and 
potentially important pharmaceutically and anti-feedant 
chemicals in bryophytes is the presence of unique odors.  
This is especially true for liverworts, with more than 
several hundred new compounds identified among them 
(Asakawa 2012).  In addition, more than 40 new carbon 
skeletal acetogenins, phenolic compounds, and terpenoids 
were identified.  Testing of these compounds has led to the 
commercial development of a natural pesticide (Frahm 
2004). 
Leptolejeunea (Figure 5) and Moerckia (Figure 6) are 
distinctly aromatic (Schuster 1966), Lophozia bicrenata 
(Figure 7) has a pleasant odor, species of Solenostoma 
(Figure 8) smell like carrots, Geocalyx graveolens (Figure 
9) has a turpentine-like odor, and Conocephalum conicum 
(Figure 10) smells like mushrooms.  The tropical 
Plagiochila rutilans (Figure 11) smells like peppermint, 
caused by several methane monoterpenoids (Heinrichs et 
al. 2001). 
 
 
Figure 5.  Leptolejeunea elliptica, a species with a distinct 
odor.  Photo by Yan Jia-dang, through Creative Commons. 
 
Figure 6.  Moerckia flotoviana female, a species with a 
distinct odor.  Photo by Michael Lüth, with permission. 
 
Figure 7.  The leafy liverwort Lophozia bicrenata.  Photo by 
Michael Lüth. 
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Figure 8.  Solenostoma hyalina, a species that smells like 
carrots.  Photo by Janice Glime. 
 
 
Figure 9.  The leafy liverwort Geocalyx graveolens.  
Underleaf is indicated by the red star.  Photo by Michael Lüth. 
 
 
Figure 10.  Conocephalum conicum, a species that smells 
like mushrooms.  Photo by Hermann Schachner, through Creative 
Commons. 
But can you imagine using mosses to lower your 
cholesterol?  Yes, mosses contain polyunsaturated fatty 
acids that are already known to have important potentials in 
human medicine, such as preventing atherosclerosis and 
cardiovascular disease, reducing collagen-induced 
thrombocyte aggregation, and lowering triacylglycerols and 
cholesterol in plasma (Radwan 1991). 
 
Figure 11.  Plagiochila sp.  Plagiochila rutilans smells like 
peppermint.  Photo by Lin Kyan, with permission. 
It appears that these unique odors result from a 
combination of many compounds, including monoterpene 
hydrocarbons such as α-pinene, ß-pinene, camphene, 
sabinene, myrcene, alpha-terpinene, limonene, fatty acids, 
and methyl esters of low molecular weight (Hayashi et al. 
1977).  For example, Isotachis japonica (Figure 12) has at 
least three aromatic esters:   benzyl benzoate, benzyl 
cinnamate, and B-phenylethyl cinnamate (Matsuo et al. 
1971). 
 
 
Figure 12.  Isotachis sp.  Isotachis japonica has at least three 
aromatic esters.  Photo by George Shepherd, through Creative 
Commons. 
But progress in purifying and identifying bryophyte 
biochemical components and demonstrating their antibiotic 
effects has been slow.  As early as 1952, Madsen and Pates 
found inhibition of microorganisms in products of 
bryophytes, including Sphagnum portoricense (Figure 13), 
S. strictum (Figure 14), Conocephalum conicum (Figure 
10), and Dumortiera hirsuta (Figure 15) (see also 
Sabovljević et al. 2011; Chandra et al. 2017).  Pavletic and 
Stilinovic (1963) found that Dicranum scoparium (Figure 
16) strongly inhibited all bacteria tested but Gram-negative 
Escherichia coli (Figure 17).  McCleary and Walkington 
(1966) considered that non-ionized organic acids and 
polyphenolic compounds might contribute to the antibiotic 
properties of bryophytes and found eighteen mosses that 
strongly inhibited one or both of Gram-positive and Gram-
negative bacteria, the most active being Atrichum (Figure 
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20), Dicranum (Figure 16), Mnium (Figure 18), 
Polytrichum (Figure 19), and Sphagnum.  Reminiscent of 
Dicranum scoparium (Figure 16), Atrichum undulatum 
(Figure 20) was effective on everything tested except 
Enterobacter aerogenes (drug resistant and infectious to 
people with weak immune systems; Figure 21) and E. coli. 
 
 
Figure 13.  Sphagnum portoricense, a species that inhibits 
microorganisms.  Photo by Blanka Shaw, with permission. 
 
 
Figure 14.  Sphagnum strictum, a species that inhibits 
microorganisms.  Photo by Jan-Peter Frahm, with permission. 
 
 
Figure 15.  Dumortiera hirsuta, a species that inhibits 
microorganisms.  Photo by Michael Lüth, with permission. 
 
Figure 16.  Dicranum scoparium, a species that inhibited all 
bacteria tested but Gram-negative Escherichia coli.  Photo by 
Janice Glime. 
 
 
Figure 17.  Escherichia coli, a species that is inhibited by 
acetone-soluble extracts of several thallose liverwort species.  
Photo by NIAID, through Creative Commons. 
 
 
Figure 18.  Mnium spinulosum.  Members of the genus 
Mnium are among the most active against one or both of Gram-
positive and Gram-negative bacteria.  Photo by Michael Lüth, 
with permission. 
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Figure 19.  Polytrichum commune.  Members of the genus 
Polytrichum are among the most active against one or both of 
Gram-positive and Gram-negative bacteria.  Photo by Michael 
Lüth, with permission. 
 
Figure 20.  Atrichum undulatum is a moss that is very 
effective against a wide range of bacteria.  Photo by Michael 
Lüth. 
 
Figure 21.  Enterobacter aerogenes, a bacterium that seems 
to be resistant to extracts of 18 moss species that negatively affect 
other bacteria.  Photo by Alexa Rakusin Muna, through Creative 
Commons. 
Gupta and Singh (1971) found high occurrence of 
antibacterial activity in extracts of Barbula species (Figure 
22), reaching as high as 36.2%, whereas it was only half 
that in Timmiella species (Figure 23) (18.8%).  In 1982, 
Asakawa et al. (1982) isolated three prenyl bibenzyls from 
Radula spp. (Figure 24) and demonstrated that these 
bibenzyls could inhibit growth of Staphylococcus aureus 
(Figure 25) at concentrations of 20.3 µg ml-1.  Out of more 
than 80 species tested, Ichikawa (1982) and coworkers 
(1983) found antimicrobial activity in nearly all.  Acyclic 
acetylenic fatty acid and cyclophentenonyl fatty acid 
extracts from the mosses completely inhibited the growth 
of the rice blast fungus Magnaporthe grisea (Figure 26).  
Belcik and Wiegner (1980) reported antimicrobial activity 
in extracts of the liverworts Pallavicinia (Figure 27) and 
Reboulia (Figure 28), and Isoe (1983) reported it from 
Porella (Figure 29). 
 
 
Figure 22.  Barbula convoluta, member of a genus with high 
antibacterial activity.  Photo by Michael Lüth, with permission. 
 
Figure 23.  Timmiella sp., a genus with high antibacterial 
activity.  Photo by Ken-ichi Ueda through Creative Commons. 
 
Figure 24.  Radula complanata, a species with bibenzyls that 
could inhibit growth of Staphylococcus aureus.  Photo by Michael 
Lüth, with permission. 
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Figure 25.  Staphylococcus aureus, a bacterium that is not 
inhibited by the thallose liverwort Riccia fluitans.  Photo by 
NIAID, through Creative Commons. 
 
 
Figure 26.  Magnaporthe grisea, a plant pest that is inhibited 
by several liverworts.  Photo by IRRI Photos, through Creative 
Commons. 
 
Figure 27.  Pallavicinia lyellii, member of a genus with 
reported antimicrobial activity.  Photo by Jan-Peter Frahm, with 
permission. 
 
Figure 28.  Reboulia hemisphaerica, member of a genus 
with reported antimicrobial activity.  Photo by Malcolm Storey 
<www.discoverlife.org>, with online permission. 
 
 
Figure 29.  Porella platyphylla, member of a genus with 
reported antimicrobial activity.  Photo by Tim Waters through 
Creative Commons. 
Another three species of mosses [Anomodon rostratus 
(Figure 30), Plagiomnium cuspidatum (Figure 31), 
Orthotrichum rupestre (Figure 32)] produce substances 
that inhibit bacteria and fungi, but these inhibitors seem to 
be unstable products that vary considerably among species 
and possibly also among seasons (McCleary et al. 1960).  
Indeed, it would appear that some of these antibiotic 
compounds are the very ones that bryophytes produce in 
response to stress.  However useful they may be, it seems 
that these discoveries have not yet found their way into 
medical practice. 
 
 
Figure 30.  Anomodon rostratus, a species that inhibits 
bacteria and fungi.  Photo by Dale A. Zimmerman Herbarium, 
Western New Mexico University, with permission. 
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Figure 31.  Plagiomnium cuspidatum, a species that inhibits 
bacteria and fungi.  Photo by Štĕpán Koval, with permission. 
 
Figure 32.  Orthotrichum rupestre, a species that inhibits 
bacteria and fungi.  Photo by Michael Lüth, with permission. 
Scientists have found innumerable kinds of biological 
activity in compounds from bryophytes.  Even in a single 
species, one might find multiple kinds of activity.  For 
example, the liverworts Plagiochasma japonica and 
Marchantia emarginata subsp. tosana (Figure 33) exhibit 
antitumor activity, antifungal and antimicrobial activity, 
inhibition of superoxide release, inhibition of thrombin 
activity, and muscle relaxation (Lahlou et al. 2000).  As is 
often the case with herbal medicine, the effect of the total 
extract is better than that of the isolated compounds, 
perhaps due to a synergistic effect (Frahm 2004). 
 
 
Figure 33.  Marchantia emarginata subsp. tosana, a 
subspecies with a wide range of medicinal properties.  Photo by 
Taiwan Mosses, through Creative Commons. 
On the other hand, some researchers claim that 
antibiotic properties of some mosses, including Sphagnum 
(Figure 13, Figure 14), may actually be the work of 
associated microorganisms.  In some cases, e.g. 
Sphagnum, it may be Penicillium sp. (Figure 34) effecting 
this antibiotic ability (Lewington 1990).  Or is it the closely 
associated Cyanobacteria, such as Nostoc (Figure 35) 
(Spjut et al. 1988; Solheim & Zielke 2002)? 
 
 
Figure 34.  Penicillium expansum on pear, in a genus that 
can grow on Sphagnum and may contribute to its antibiotic 
effects.  Photo by H. J. Larsen, through Creative Commons. 
 
 
Figure 35.  Nostoc pruniforme, in a genus with close 
associations with Sphagnum and other bryophytes and could 
contribute to antibiotic properties.  Photo by Lairich Rig, through 
Creative Commons. 
Painter (2003) notes that Sphagnum (Figure 13, Figure 
14) can be 3-4 times as absorbent as cotton equivalents.  
But its call to fame seems to be its ability to react 
chemically with all sorts of proteins.  Sphagnum species 
have the potential to immobilize whole bacterial cells, 
enzymes, exotoxins, and lysins that are secreted by most of 
the invasive pathogens.  Once these are immobilized, they 
are inactivated by a Maillard reaction. 
The Maillard reaction makes this story complex.  It is 
known to suppress the virulence gene expression operon in 
the bacterium Listeria monocytogenes (Figure 36) (Sheikh-
Zeinoddin et al. 2000), so that is a good thing.  On the 
other hand, a variety of foods form potential cancer-causing 
acrylamides, especially fried foods (Stadler et al. 2002).  
Such acrylamides can be released by thermally treating 
certain amino acids such as asparagine, especially in 
combination with reducing sugars through the Maillard 
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reaction.  The early Maillard reaction products are N-
glycosides.  Painter (1998) found that the Maillard reaction 
inhibits microbial growth in animal products preserved in 
bogs by sequestering ammonia, amino acids, and peptides, 
whereas the polymeric end-products (melanoidins) inhibit 
their growth by cross-linking the polypeptide chains and 
sequestering essential multivalent metal cations.  In short, 
the Maillard reaction appears to be an important component 
of the Sphagnum (Figure 13, Figure 14) antibiotic activity.  
Furthermore, its preservative ability correlates with α-keto-
carboxylate groups in a glycuronoglycan (sphagnan) that 
comprises ∼60% of the holocellulose in the Sphagnum 
hyaline cell walls. 
 
 
Figure 36.  Listeria monocytogenes, a bacteria species that is 
inhibited by extracts of the leafy liverwort Porella cordaeana.  
Photo from CDC, through public domain. 
Harris (2009) considered phylogenetic, elevational, 
and latitudinal relationships of the production of flavonoids 
in medicinal mosses.  He was unable to show any 
significant correlation between phylogenetic independent 
contrasts of total phenolic content, number of flavonoids, 
or percent luteolin derivatives.  He furthermore found no 
correlation with elevation or latitude.  He could not rule out 
the possible correlation with fine-scale ecological features, 
and he considered flavonoid variation to reflect recent 
evolution. 
Labbé et al. (2007) tested the thallose liverwort 
Riccardia polyclada for potential pesticidal properties.  
They identified four compounds that contributed to 
lethality in the brine shrimp (Artemia salina; Figure 37).  
Two of the compounds had moderate activity as an 
antifeedant for the African cotton leafworm (Spodoptera 
littoralis; Figure 38).  They also inhibited culture growth of 
the fungal plant pathogen Cladosporium herbarum (Figure 
39). 
 
 
Figure 37.  Artemia salina, a species that is killed by extracts 
from the liverwort Riccardia polyclada.  Photo by Hans 
Hillewaert, through Creative Commons. 
 
Figure 38.  Spodoptera littoralis, a species that is 
discouraged from eating the liverwort Riccardia polyclada by its 
chemical compounds.  Photo from Forestry Images, through 
Creative Commons. 
 
Figure 39.  Cladosporium spp., fungal pathogens that are 
inhibited by extracts from the liverwort Riccardia polyclada.  
Photo from Mold Treatment Centers of America, through Creative 
Commons. 
Antimicrobial Activity 
Our knowledge of antimicrobial activity of bryophytes 
is mostly based on Sphagnum (Figure 13, Figure 14).  
However other bryophytes are now known to have 
antibiotic properties.  Some of these may just be folklore as 
they have not been tested experimentally.  For example, 
Cheng et al. (2008) reported the folk use of Polytrichum to 
treat pneumonia.  And we have already seen that 
Polytrichum commune (Figure 19) is used in a tea for 
treating colds (Gulabani 1974; Beike et al. 2010). 
Nevertheless, antibiotic properties have been 
demonstrated in the laboratory.  Moss activity against 
Gram-positive and Gram-negative bacteria have been 
demonstrated (Basile et al. 1999; Merkuria et al. 2005; Zhu 
et al. 2006).  Asakawa (2007a, b) has demonstrated many 
effects of liverworts. 
Kumar et al. (2007), in their review of classical 
ethnobotanical Indian uses, reported the antibacterial value 
of the mosses Anomodon rostratus (Figure 30), Atrichum 
angustatum (Figure 40), A. undulatum (Figure 41), and 
Hyophila involuta (Figure 42) and the thallose liverworts 
Conocephalum conicum (Figure 10) and Dumortiera 
hirsuta (Figure 15).  These bryophytes reportedly produce 
antibiotics.  The leafy liverwort Radula complanata 
(Figure 24) similarly has antimicrobial properties.  To these 
we can add the antiseptic properties of Frullania tamarisci 
(Figure 43) (Asakawa 2007b; Chandra et al. 2017) and 
antimicrobial activity of Pallavicinia sp. (Figure 27) 
(Azuelo et al. 2011; Chandra et al. 2017). 
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Figure 40.  Atrichum angustatum, a species with 
antibacterial properties.  Photo by Janice Glime. 
 
 
 
Figure 41.  Atrichum undulatum, a species with 
antibacterial properties.  Photo by Brian Eversham, with 
permission. 
 
 
 
Figure 42.  Hyophila involuta, a species with antibacterial 
properties.  Photo by Michael Lüth, with permission. 
 
Figure 43.  Frullania tamarisci, an epiphytic species with 
antiseptic properties, having both allergenic and medicinal 
properties.  Photo by Michael Lüth, with permission. 
Recent tests on the floating thallose liverwort Riccia 
fluitans (Figure 44) from Florida indicated no ability to 
inhibit growth of the tested bacteria [Pseudomonas 
aeruginosa (Figure 45), Staphylococcus aureus (Figure 
25)] or yeast (Candida albicans; Figure 46) (Pates & 
Madsen 1955).  Vashistha et al. (2007) determined the 
antimicrobial activity of three other thallose liverworts.    
They found that water soluble extracts from 
Conocephalum conicum (Figure 10), Marchantia 
polymorpha (Figure 47), and Plagiochasma 
appendiculatum (Figure 48) had no effect on any of the 
pathogens tested [Gram-negative bacteria Escherichia coli 
(Figure 17) and Salmonella typhi (a variant of S. enterica; 
Figure 49)] and fungi Aspergillus niger (Figure 50) and 
yeast Candida albicans (Figure 46).  However, acetone-
soluble extracts of all three bryophyte species were 
inhibitory against the pathogens.  They were more effective 
against the growth of S. typhi than against E. coli.  
Plagiochasma appendiculatum had a strong inhibitory 
effect against A. niger and Conocephalum conicum was 
strongly inhibitory to Candida albicans. 
 
 
Figure 44.  Riccia fluitans, a species that was unable to 
inhibit the growth of several tested bacteria.  Photo by Štĕpán 
Koval, with permission. 
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Figure 45.  Pseudomonas aeruginosa, a species that is not 
inhibited by Riccia fluitans.  Photo by Janice Haney Carr, 
through Creative Commons. 
 
 
Figure 46.  Candida albicans, a yeast species that is inhibited 
by extracts of the liverworts Conocephalum conicum, 
Marchantia polymorpha, and Plagiochasma appendiculatum, 
but not Riccia fluitans.  Photo from Public Health Image Library, 
through public domain. 
 
 
Figure 47.  Marchantia polymorpha subsp. ruderalis.  This 
species had no effect on the fungi or Gram negative bacteria 
tested by Vashistha et al.  Photo by Malcolm Storey, through 
Creative Commons 
 
Figure 48.  Plagiochasma appendiculatum, a species that is 
effective against some pathogens.  Photo by Ying Jia-dong, 
through Creative Commons. 
 
Figure 49.  Salmonella enterica invading human cells.  
Photo by NIAID, through public domain. 
 
Figure 50.  Aspergillus niger, a fungal species that is 
inhibited by extracts of the liverworts Conocephalum conicum, 
Marchantia polymorpha, and Plagiochasma appendiculatum.  
Photo from Public Health Image Library, through public domain. 
Bukvicki et al. (2012), using solid-phase 
microextraction-gas chromatography mass spectrometry, 
explored the volatile components of the leafy liverwort 
Porella cordaeana (Figure 51).  Using methanol, ethanol, 
and ethyl acetate to extract terpenoids, they were able to 
identify sesquiterpene hydrocarbons and monoterpene 
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hydrocarbons.  These same hydrocarbons were active 
against the eleven food microorganisms tested, but at 
different concentrations among the microorganisms.  The 
fungi among these will be discussed blow.  Affected 
bacterial strains were Salmonella enteritidis (food 
poisoning that causes diarrhea, fever, and abdominal 
cramps; Figure 52), Escherichia coli (commonly found in 
lower intestine of warm-blooded organisms with some 
strains causing food poisoning; Figure 17), and Listeria 
monocytogenes (very virulent food pathogen that causes the 
infection listeriosis; Figure 36).  Methanol extracts showed 
the best activity. 
 
 
 
Figure 51.  Porella cordaeana, a species that is able to 
inhibit a variety of yeasts and bacteria.  Photo by J. C. Schou, with 
permission. 
 
 
Figure 52.  Salmonella enteritidis, a bacteria species that is 
inhibited by extracts of  Porella cordaeana.  Photo through OGL 
(public domain). 
It appears that differences in bryophyte extract activity 
among various pathogens may be common.  Extracts of the 
liverworts Marchantia polymorpha (Figure 47), Porella 
platyphylla (Figure 29), and the moss Dicranum 
scoparium (Figure 16) showed antimicrobial effects on the 
Gram-positive bacteria Bacillus subtilis (Figure 53), 
Staphylococcus aureus (Figure 25), and Micrococcus luteus 
(Figure 54) (Pavletic & Stilinovic 1963; Frahm 2004).  
These same bryophytes exhibited no activity against Gram-
negative Escherichia coli (Figure 17). 
 
Figure 53.  SEM of Bacillus subtilis, a species that is 
inhibited by extracts of several bryophyte species.  Photo by 
Davehwng, through Creative Commons. 
 
Figure 54.  Micrococcus luteus, a bacteria species that is 
inhibited by extracts of several bryophyte species.  Photo by 
Janice Carr, through public domain. 
Basile et al. (1999) isolated seven pure flavonoids 
from five species of mosses.  Some of these exhibited 
strong antibacterial effects against the bacteria 
Enterobacter cloaceae (Figure 55), E. aerogenes (Figure 
56), and Pseudomonas aeruginosa (Figure 45).  They were 
mainly active against Gram-negative bacteria that caused 
severe opportunistic infections and were at the same time 
resistant to commonly used antibacterial therapy.  This 
means that the bryophyte products could become important 
tools in treating some bacterial infections. 
 
 
Figure 55.  Enterobacter cloaceae, a species that is active 
against Gram-negative bacteria.  Photo by Nathan Reading, 
through Creative Commons. 
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Figure 56.  Enterobacter aerogenes, a species that is active 
against Gram-negative bacteria.  Photo by Riraq25, through 
Creative Commons. 
Ariyo et al. (2011) compared the efficacy of extracts 
from the Nigerian thallose liverwort Riccia nigerica as 
antimicrobial agents.  These extracts were tested against the 
bacteria Bacillus subtilis (Figure 53), Pseudomonas 
aeruginosa (Figure 45), Shigella dysenteriae (Figure 57), 
and Staphylococcus aureus (Figure 25) and fungi Rhizopus 
spp. (Figure 58), Aspergillus flavus (Figure 59), A. niger 
(Figure 50), Penicillium spp. (Figure 34), and and 
demonstrated strong significant antibacterial and antifungal 
activity. 
 
 
Figure 57.  Shigella dysenteriae, a bacterial species that is 
inhibited by extracts of Riccia nigerica.  Photo by Public Health 
Image Library, through public domain. 
 
Figure 58.  Rhizopus on yam, a fungal species that is 
inhibited by extracts of Riccia nigerica.  Photo by Charles 
Averre, through Creative Commons. 
 
Figure 59.  Aspergillus flavus, a fungal species that is 
inhibited by extracts of Riccia nigerica.  Photo by Medmyco, 
through Creative Commons. 
The leafy liverwort Ptilidium pulcherrimum (Figure 
60) exhibits antimocrobial activity against both Gram + 
bacteria and Gram negative bacteria, but the effect is 
greater on the Gram positive bacteria (Veljić et al. 2010). 
 
 
Figure 60.  Ptilidium pulcherrimum, a species that is 
effective against both Gram positive and Gram negative bacteria.  
Photo by Hermann Schachner, through Creative Commons 
Antifungal Activity 
Although mosses are known to harbor fungi and will 
quickly become infected if kept moist in a plastic bag, 
some fungi are inhibited by many species of bryophytes, 
including many that cause skin infections.  Jennings (1926) 
reported moss immunity to molds as early as 1926, but the 
possibility of using them as a source of antifungal activity 
seems to have been largely overlooked.  Among these, the 
cosmopolitan moss Hypnum cupressiforme (Figure 61) 
has remarkable antibacterial and antifungal effects.  Ven 
Hoof et al. (1981) demonstrated strong antibacterial and 
antifungal effects by extracts of Hypnum cupressiforme. 
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Figure 61.  Hypnum cupressiforme, a species that is 
effective against fungi that cause skin infections.  Photo by 
Michael Lüth. 
Kumar et al. (2007) report antifungal properties for the 
widespread leafy liverwort Porella platyphylla (Figure 29).  
Ando and Matsuo (1984) demonstrated antifungal effects 
of bryophytes on human pathogenic fungi, but they warned 
that while the bryophyte extracts have fungicidal and 
antifeedant effects, they also may cause allergic reactions 
and dermatitis for some humans. 
Bukvicki et al. (2012), using solid-phase 
microextraction-gas chromatography mass spectrometry, 
explored the volatile components of the related liverwort 
Porella cordaeana (Figure 51).  Using methanol, ethanol, 
and ethyl acetate to extract terpenoids, they were able to 
identify sesquiterpene hydrocarbons and monoterpene 
hydrocarbons.  These same hydrocarbons were active 
against the eleven food microorganisms tested, but at 
different concentrations among the microorganisms.  These 
included the yeasts Saccharomyces cerevisiae (yeast used 
in wine making, baking, and brewing, but antibodies 
against S. cerevisiae are found in 60-70% of patients with 
Crohn's disease; Figure 62), Zygosaccharomyces bailii 
(species causing significant spoilage in the food industry; 
Figure 63), Aureobasidium pullulans (an inhabitant 
of humidifiers or air conditioners that can lead to 
hypersensitivity pneumonitis; Figure 64), Pichia 
membranifaciens (species causing grey mold of fruits; 
Figure 65) (2 strains), Pichia anomala (used in 
winemaking) (2 strains), and Yarrowia lipolytica (used in 
industrial microbiology for production of specialty lipids).  
Methanol extracts showed the best activity. 
 
 
Figure 62.  Saccharomyces cerevisiae SEM, a yeast species 
that is inhibited by extracts of the leafy liverwort Porella 
cordaeana.  Photo by Mogana Das Murtey and Patchamuthu 
Ramasamy, through Creative Commons. 
 
Figure 63.  Zygosaccharomyces bailii, a yeast species that is 
inhibited by extracts of  Porella cordaeana.  Photo by DTDT, 
through Creative Commons. 
 
 
 
Figure 64.  Aureobasidium pullulans, a yeast species that is 
inhibited by extracts of the leafy liverwort Porella cordaeana.  
Photo by Tom Volk, through Creative Commons. 
 
 
 
Figure 65.  Pichia membranaefaciens, a yeast species that is 
inhibited by extracts of  Porella cordaeana.  Photo by Luciana 
Francisco Fleuri & Hélia Harumi Sato, through Creative 
Commons. 
 
The leafy liverwort Ptilidium pulcherrimum (Figure 
60) is not only effective against bacteria, but also against 
fungi (Veljić et al. 2010).  Its best antifungal activity was 
against Trichoderma viride (Figure 66), compared to the 
activity of the synthetic bifonazol. 
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Figure 66.  Trichoderma viride conidiophores, a fungal 
species that is inhibited by Atrichum undulatum, Physcomitrella 
patens, and Marchantia polymorpha.  Photo by Ninjatacoshell, 
through Creative Commons. 
The absence of fungal diseases in liverworts led Pryce 
(1972) to suggest that lunularic acid, a hormone that 
affects aging in liverworts but not in mosses, might be 
responsible for liverwort antifungal activity.  Banerjee and 
Sen (1979; Bannerjee 1974) found that the degree of 
antibiotic activity in a given species may depend on the age 
of the gametophyte; Matsuo et al. (1982a, 1982b, 1983) 
supported this conclusion by demonstrating that antifungal 
activity against Botrytis cinerea (Figure 67), Pythium 
debaryanum (Figure 68), and Rhizoctonia solani (Figure 
69) by the liverwort Herbertus aduncus (Figure 70) was 
age-dependent.  They subsequently isolated three aging 
substances from it:  (-)-alpha-herbertenol; (-)-Beta-
herbertenol, and (-)-alpha-formylherbertenol. 
 
 
Figure 67.  Botrytis cinerea on grapes.  The liverwort 
Herbertus aduncus can exercise antifungal activity against this 
fungus, but activity is age-dependent.  Photo by Alexandre 
Dulaunoy, through Creative Commons. 
 
Figure 68.  Pythium sp.  The liverwort Herbertus aduncus 
can exercise antifungal activity against this fungus, but activity is 
age-dependent.  Photo by Josef Reischig, through Creative 
Commons. 
 
Figure 69.  Rhizoctonia solani infecting leaves.   The 
liverwort Herbertus aduncus can exercise antifungal activity 
against this fungus, but activity is age-dependent.  Photo by 
Howard F. Schwartz, through Creative Commons. 
 
 
Figure 70.  Herbertus aduncus, a leafy liverwort that can 
exercise antifungal activity against several fungi, but activity is 
age-dependent.  Photo by Martin Hutten, with permission. 
Vashistha et al. (2007) determined the antimicrobial 
activity for the thallose liverworts Plagiochasma 
appendiculatum (Figure 48), Marchantia polymorpha 
(Figure 47), and Conocephalum conicum (Figure 10).  
Acetone-soluble extracts of all three bryophyte species 
2-2-16  Chapter 2-2:  Medical Uses:  Biologically Active Substances 
were inhibitory against the fungal pathogens tested.  
Plagiochasma appendiculatum had a strong inhibitory 
effect against Aspergillus. niger and C. conicum was 
strongly inhibitory to Candida albicans.  When Niu et al. 
(2006) tested Marchantia polymorpha (Figure 47) for 
antifungal activities against the yeast Candida albicans 
(Figure 46), they found plagiochin E, 13,13'-O-
isoproylidenericcardin D, and neomarchantin A were active 
against the yeast.  The other identified compounds had only 
weak effects. 
Sabovljević et al. (2011) used DMSO extracts of both 
cultured and wild grown mosses Atrichum undulatum 
(Figure 20) and Physcomitrella patens (Figure 71-Figure 
72) and thallose liverwort Marchantia polymorpha ssp. 
ruderalis (Figure 47) to test for antifungal activity.  Using 
Aspergillus versicolor (Figure 73), Aspergillus fumigatus 
(Figure 74), Penicillium funiculosum (see Figure 34), 
Penicillium ochrochloron, and Trichoderma viride (Figure 
66), these researchers demonstrated antifungal activity by 
all three bryophytes against all five fungal species.  Most of 
the bryophytes grown in culture had greater antibiotic 
activity than the wild-grown ones. 
 
 
Figure 71.  Physcomitrella patens growing on agar plates.  
Photo by Sabisteb, through Creative Commons. 
 
 
Figure 72.  Physcomitrella patens, a source of human 
proteins and blood-clotting factor IX.  Photo by Michael Lüth. 
 
Figure 73.  Aspergillus versicolor, a fungal species that is 
inhibited by Atrichum undulatum, Physcomitrella patens, and 
Marchantia polymorpha.  Photo by James Scott, through 
Creative Commons. 
 
 
 
Figure 74.  Aspergillus fumigatus, a fungal species that is 
inhibited by Atrichum undulatum, Physcomitrella patens, and 
Marchantia polymorpha.  Photo through Creative Commons. 
Alcoholic extracts of all twenty bryophytes tested at 
Bonn University had antifungal activity on infected crops 
(Frahm 2004), as demonstrated in a Petri dish (Figure 75).  
Frahm reports curing a fungal infection of the skin with a 
bryophyte extract.  The success was reported in a TV 
magazine and a published book, causing a number of 
people to use the extract for fungal infections, mostly with 
favorable results.  However, Frahm warns that the 
biologically active substances are terpenoids, and these 
may cause allergic effects to some people (Ando & Matsuo 
1984).  One reputedly can cure athlete's foot by walking 
through a peat bog, presumably because of these same 
terpenoids (Frahm 2004). 
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Figure 75.  Bryophytes are known to inhibit growth of some 
kinds of bacteria and fungi.  Left:  Microbes grow uninhibited 
around a disk with only extraction fluid.  Right:  A zone of 
inhibition occurs around the disk with bryophyte extract.  Photo 
by Jan-Peter Frahm. 
One extract has actually been patented to cure fungal 
infections of horses (Frahm 2004).  An industrious horse 
owner was inspired by what he read about the Bonn 
experiments and made a paste of Ceratodon purpureus 
(Figure 76) and Bryum argenteum (Figure 77).  The 
fungus disappeared from the horse in 24 hours!  This same 
extract is also sold as a human foot cream to refresh and 
fight odor.  Unfortunately, the use for curing fungal 
infections cannot be mentioned in advertising because then 
it would require the extensive testing necessary to meet 
medical approval, which might be difficult because it can 
cause allergies and dermatitis in some people.  It also 
works as an antifeedant against slugs.  Unfortunately, to 
date it must be extracted from field-collected material, 
creating conservation concerns. 
 
 
Figure 76.  Ceratodon purpureus, a species was used with 
Bryum argenteum and killed a fungal infection on a horse.  Photo 
by Janice Glime. 
It appears that some bryophytes may contribute to 
antifungal compounds by hosting a fungus that 
manufactures both antifungal and antitumor compounds 
(Guo et al. 2008).  The leafy liverwort Scapania verrucosa 
hosts the fungus Chaetomium fusiforme (Figure 78).  Not 
only does the latter produce both antifungal and antitumor 
compounds, but the liverwort itself likewise produces them.  
However, the fungus compounds provide superior 
properties and the liverwort might contribute to the 
medicinal field through this fungal endophyte (organisms 
growing within cells of plant, ranging from symbiotic to 
parasitic). 
 
 
Figure 77.  Bryum argenteum, a species that was used in a 
paste with Ceratodon purpureus and killed a fungal infection on 
a horse.  Photo by Martin Hutten, with permission. 
 
 
Figure 78.  Chaetomium globosum.  The fungus 
Chaetomium fusiforme occurs on Scapania verrucosa and 
produces both antifungal and antitumor compounds.  Photo by 
Ulitca, through Creative Commons. 
Antiviral Activity 
Even viruses may some day be cured by extracts of 
mosses, but we cannot simply identify them as "moss" as 
many of our ecologist friends have been wanton to do in 
reporting the ground cover.  The Maoris of New Zealand 
have used bryophytes to treat venereal disease by packing 
wet plants on the infected organs (Frahm 2004).  
Nevertheless, van Hoof and coworkers (1981) found no 
effect of 20 species of moss extracts on the herpes virus, 
but earlier Klöcking et al. (1976) found that at least some 
peat humic acids possess antiviral activity against herpes 
simplex virus types 1 and 2, interfering primarily with the 
adsorption of viruses to host cells.   
Sphagnum (Figure 13, Figure 14) produces several 
antivirally active humic acids, and Camptothecium (Figure 
79) extracts can inhibit growth of the poliovirus (Witthauer 
et al. 1976; van Hoof et al. 1981).  Nevertheless, actual 
usage of bryophytic extracts has not developed outside of 
Asia. 
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Figure 79.  Camptothecium lutescens, in a genus that can 
inhibit growth of the poliovirus.  Photo by David T. Holyoak, 
with permission. 
Cancer and Anti-tumor Properties 
In the same year as the Madsen and Pates (1952) report 
of antibiotics in bryophytes, Belkin et al. (1952-53) 
reported anticancer activity against Sarcoma 37 in mice, 
using extracts of Polytrichum juniperinum (Figure 80).    
But application of the antitumor activity fared no better and 
was apparently not rediscovered in bryophytes until the 
next century.  Finally, Anterola et al. (2009) considered the 
anticancer drug precursors in mosses to be so important 
that they titled their presentation on them "Turning 
precursors into gold:  Production of anticancer drug 
precursors in moss." 
 
 
Figure 80.  Polytrichum juniperinum with antheridial splash 
cups, a species that produces anticancer compounds.  Photo by 
Paul Slichter, with permission. 
Fu et al. (2009) attempted to show anti-cancer 
capabilities of the moss Polytrichum commune (Figure 
19).  To this end, they isolated two "unusual" flavones and 
other compounds from this moss.  However, when tested 
against a small panel of cancer cell lines, they failed to find 
any activity. 
Kumar et al. (2007) found that Indians have used 
Polytrichum juniperinum (Figure 80) to treat cancer.  The 
anti-tumor use of bryophytes in India included 
Chiloscyphus polyanthos (Figure 81), Diplophyllum 
albicans  (Figure 82), D. taxifolium (Figure 85), 
Marchantia palmata, and M. polymorpha (Figure 47).  
Frullania tamarisci (Figure 43) is used as an antileukemic 
agent.  To this list, others added Riccardia sp. (Figure 84) 
(Azuelo et al. 2011; Alam 2012; Chandra et al. 2017) and 
Plagiochila sp. (Figure 11) (Asakawa 2007; Alam 2012; 
Chandra et al. 2017). 
 
 
 
Figure 81.  Chiloscyphus polyanthos, a species that may 
cause allergic reactions.  Photo by Barry Stewart, with 
permission. 
 
 
Figure 82.  Diplophyllum albicans, used as an anti-tumor 
treatment in India and as an agent against epidermoid carcinoma.  
Photo by Michael Lüth, with permission. 
Asakawa (1981) has shown that several compounds 
from leafy liverworts exhibit antileukemic activity.  From 
the thallose species, Marchantin A from Marchantia 
palacea (Figure 83), M. polymorpha (Figure 47), and M. 
emarginata subsp. tosana (Figure 33), riccardin from 
Riccardia multifida (Figure 84), and perrottetin E from 
Radula perrottetii all show cytotoxicity against the 
leukemic KB cells (Asakawa et al. 1982).   
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Figure 83.  Marchantia paleacea, a thallose liverwort known 
for its antileukemic activity.  Photo by Jan-Peter Frahm, with 
permission. 
 
 
Figure 84.  Riccardia multifida, a thallose liverwort known 
for its antileukemic activity.  Photo by Michael Lüth, with 
permission. 
In 1976, Adamek reported that peat preparations hold 
some promise against some types of human cancer.  In 
1977, Ohta and coworkers (1977) reported that 
diplophyllin, isolated from the liverworts Diplophyllum 
albicans (Figure 82) and D. taxifolium (Figure 85), shows 
significant activity (ED50 4-16 µg/ml) against human 
epidermoid carcinoma (KB cell culture). 
 
 
Figure 85.  Diplophyllum taxifolium, a species that produces 
diplophyllin, a compound that is active against human epidermoid 
carcinoma.  Photo by Hermann Schachner, through Creative 
Commons. 
Hughes and Anterola (2010) attempted to transplant 
genes for producing Taxol (a potent anticancer agent) into 
the moss Physcomitrella patens (Figure 71, Figure 72).  
They found evidence of small amounts of the anticancer 
precursors in the moss.  If the moss can be taught 
(genetically) to produce Taxol, it could become a 
laboratory means to manufacture this important anti-cancer 
drug without destroying the diminishing number of Taxus 
(Figure 86) shrubs that produce it naturally.  Bryophytes 
are ideal organisms for such gene transplants because of 
their dominant state with a single set of chromosomes and 
the relative ease with which genes can be put into them. 
 
 
Figure 86.  Taxus baccata, member of the genus that 
produces the anticancer agent Taxol.  Photo through Creative 
Commons. 
When Asakawa (1981, 1982) entered the arena, he 
isolated the sesquiterpenoids costunolide and tulipinolide 
from Conocephalum supradecompositum, Frullania 
monocera, F. tamarisci (Figure 43), Marchantia 
polymorpha (Figure 47), Wiesnerella denudata (Figure 87) 
and Porella japonica (Figure 88).  To this list, Matsuo and 
coworkers (1980, 1981a, b, c, 1984) added Lepidozia vitrea 
(Figure 89) and Plagiochila semidecurrens (Figure 90).  
These substances, already known from higher plants, have 
activity to combat carcinoma of the nasopharynx, at least in 
cell culture. 
 
 
Figure 87.  Wiesnerella denudata, a species that produces 
sesquiterpenoids that are likely to have antibiotic properties.  
Photo by Ying Jia-dong, through Creative Commons. 
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Figure 88.  Porella japonica, a species that produces 
compounds that combat carcinoma of the nasopharynx.  Photo  
from Taiwan mosses color illustrations, through Creative 
Commons. 
 
 
 
 
 
 
Figure 89.  Lepidozia vitrea, a species that produces 
compounds that combat carcinoma of the nasopharynx.  Photo by 
Lin Shanxiong, through Creative Commons. 
 
Figure 90.  Plagiochila semidecurrens, a species that 
produces compounds that combat carcinoma of the nasopharynx.  
Photo by Martin Hutten, with permission. 
When the National Cancer Institute became interested, 
Spjut and his coworkers (1986) tested 184 species of 
mosses and 23 species of liverworts for antitumor activity.  
Of these, 43 species contained active substances, while 
those of 75 species were toxic to tested mice.  The most 
activity was found in Brachytheciaceae (Figure 91), 
Dicranaceae (Figure 16), Grimmiaceae (Figure 92), 
Hypnaceae (Figure 61), Mniaceae (Figure 18, Figure 31), 
Neckeraceae (Figure 2), Polytrichaceae (Figure 19, 
Figure 80), and Thuidiaceae (Figure 93).  However, in 
1988, doubt was cast on the role of the moss when this 
team reported that the antitumor activity of the moss 
Claopodium crispifolium (Figure 94) was greatest in 
samples contaminated with the Cyanobacterium Nostoc cf. 
microscopicum (Figure 95), suggesting that Nostoc could 
be the direct source of the activity or a necessary partner 
for interaction between the species (Spjut et al. 1988).  
Interaction could result from the transfer of a precursor 
from the Nostoc to the moss, which could then transform it 
into an active substance.  Alternatively, the moss might 
produce the substance as an allelopathic response to the 
Nostoc.  In any event, this raises important and intriguing 
questions, both medically and ecologically. 
 
 
Figure 91.  Brachythecium salebrosum (Brachytheciaceae).  
Some members of this family exhibit high antitumor activity.  
Photo by Hermann Schachner, through Creative Commons. 
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Figure 92.  Grimmia nutans (Grimmiaceae).  Some 
members of this family exhibit high antitumor activity.  Photo by 
Michael Lüth, with permission. 
 
 
Figure 93.  Thuidium tamariscinum (Thuidiaceae).  Some 
members of this family exhibit high antitumor activity.  Photo by 
Malcolm Storey (DiscoverLife.com), with online permission. 
 
 
Figure 94.  Claopodium crispifolium, a moss that provides 
habitat for Nostoc, which in turn has anti-tumor properties.  Photo 
from Botany Website, UBC, with permission. 
 
Figure 95.  Nostoc sp., a moss contaminant that can increase 
anti-tumor activity.  Photo from Retina, through Creative 
Commons. 
For some reason, much of the biochemical work has 
concentrated on the liverworts.  Similar studies on activities 
of moss compounds are sparse and there may be good 
reason to presume a greater medical treasure chest among 
the liverworts.  Since these compounds generally benefit 
the bryophytes by discouraging their would-be herbivores, 
it is the tiny, slow-growing liverworts that stand to benefit 
most.  Where other, larger plants have spent their 
evolutionary history developing a diversity of structure, it 
would seem that small size has afforded these plants only 
the benefits of diversity of biochemistry as a means of 
combating the hungry herbivores. 
Burgess et al. (2000) found that the leafy liverwort 
Bazzania novae-zelandiae (Figure 96) produces a 
sesquiterpene caffeate that has selective activity against 
certain human tumor cells.  The active compound has been 
identified as the new compound naviculyl caffeate. 
  
 
Figure 96.  Bazzania novae-zealandiae, a species that is 
active against human tumor cells.  Photo by Shirley Kerr, with 
permission. 
Even breast cancer sufferers might benefit from 
bryophytes.  Huang et al. (2010) found that marchantin A 
produced by Marchantia emarginata subsp. tosana 
(Figure 33) induced apoptosis in MCF-7 breast cancer 
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cells.  This compound demonstrates strong antioxidant 
activity, scavenging free radicals.   
The leafy liverwort Scapania verrucosa and its 
endophytic fungal inhabitant Chaetomium fusiforme (see 
Figure 78) produce several compounds that act as 
antitumor agents (Guo et al. 2008). 
The thallose liverwort Dumortiera hirsuta (Figure 15) 
produces riccardin D, a macrocyclic bisbibenzyl 
compound that induces apoptosis of human leukemia cells 
(Xue et al. 2012).  Xue and coworkers verified anticancer 
activity by riccardin D against human non-small cell lung 
cancer.  In mice it produced a 44.5% inhibition of cancer 
growth with no apparent toxicity. 
Pharmaceutical Production 
Welcome to Greenovation!  Moss for a healthy future.  
So began the website <http://www.greenovation.com/> of 
an upstart company that is growing the tiny Physcomitrella 
patens (Figure 71, Figure 72) for medicinal purposes.  Yes, 
bryophytes have indeed finally penetrated the forefront of 
modern medicine! 
Physcomitrella patens (Figure 71, Figure 72) is able to 
accept transferred human genes and express them to 
produce human antibodies in a liquid culture, making the 
antibodies easy to harvest (ETH Zurich 2009).  So far, this 
is not possible when the genes are transplanted into "higher' 
organisms.  One advantage of Physcomitrella patens is its 
ability to grow in a "bioreactor" (Figure 97; Decker & 
Reski 2004), a fermenter in which only water and minerals 
are needed to nourish the moss, of course in the presence of 
light and CO2 (Greenovation).  These tiny plants are actually superior (and cheaper) production systems for 
many complex recombinant pharmaceuticals (Bauer et al. 
2005; Decker & Reski 2007, 2012; Gitzinger et al. 2009).  
Contrary to many mammalian systems that have been used 
to produce pharmaceuticals but that cause serious immune 
responses, those produced by Physcomitrella patens are 
non-immunogenic, a huge advantage for the patient, and 
making them superior to currently used mammalian cell 
lines for producing antibodies. 
Among its many assets, Physcomitrella patens (Figure 
71, Figure 72) is able to produce human proteins (Hohe et 
al. 2002; Decker et al. 2003) and is the only plant being 
used to produce the blood-clotting factor IX for 
pharmaceutical use.  This discovery, patented by Prof. 
Reski of the Institute of Biotechnology of Plants at the 
University of Freiburg in Germany, led to the founding of 
the Greenovation Company in 1999.  By 2002, the 
company was already employing 30 people to produce this 
valuable blood factor (Frahm, Bryonet discussion 2002). 
Bryophytes offer the researchers, and the company, a 
number of advantages over "higher" plants.  They can be 
grown without antibiotics, hence avoiding the danger of 
contamination of the final product.  The moss is quite small 
and thus is cultured only in the lab with little danger of the 
transgenic plants escaping into the environment.  But the 
real advantage comes from the dominant gametophytic 
generation of mosses as opposed to the dominant 
sporophyte of the tracheophytes.  As a result, mosses are 
the only plants known to have a high frequency of 
homologous recombination.  The result – stable integration 
of inserted genes into the genome.  Furthermore, the highly 
complex moss system, compared to bacteria and fungi, 
permits a much wider array of expression than is possible 
in those systems.  Thus, mosses are extremely useful as 
production systems for targeted substances that can be 
produced through gene manipulation. 
 
 
 
Figure 97.  This type of bioreactor is used to grow 
Physcomitrella patens for human proteins and human blood-
clotting factor IX.  Photo by Ralf Reski.  
 
 
Unfortunately, most biologically active substances so 
far obtained have not proved economical for use, at least in 
part due to the slow-growing nature and difficulty of 
culturing bryophytes.  And, while their pharmaceutical use 
seems promising, we lack any understanding of their 
potential harmful side effects.  
In the words of Ma et al. (2003), "Imagine a world in 
which any protein, either naturally occurring or designed 
by man, could be produced safely, inexpensively and in 
almost unlimited quantities using only simple nutrients, 
water and sunlight. This could one day become reality as 
we learn to harness the power of plants for the production 
of recombinant proteins on an agricultural scale. Molecular 
farming in plants has already proven to be a successful way 
of producing a range of technical proteins. The first plant-
derived recombinant pharmaceutical proteins are now 
approaching commercial approval, and many more are 
expected to follow." 
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Medical Dangers 
Caution is in order in exercising any medicinal use of 
bryophytes, particularly liverworts, because of their 
potential for causing allergic reactions (Mitchell et al. 
1969, 1970; Benezra et al. 1985, Asakawa 2012).  Often 
the very compounds that have these medical potentials can 
cause allergic reactions.  For example, it is a sesquiterpene 
lactone (Asakawa 1981) that gives the common epiphyte 
Frullania (Figure 98-Figure 99) its ability to cause contact 
dermatitis, especially to forest workers (Mitchell et al. 
1969).  Now there is a patch test with a sesquiterpene 
lactone mix to determine sensitivity to Frullania (Quirce et 
al. 1994). 
Yet sesquiterpene lactones are well known for their 
antimicrobial activity.  In southern Europe, Frullania 
tamarisci (Figure 43, Figure 98) imparts an allergic 
reaction to olive pickers, yet is listed as one of the 
medicinal species (J. Curnow, pers. comm.).  D. H. Wagner 
(pers. comm.) reports an allergy to Chiloscyphus 
polyanthos (Figure 81), especially when he squeezes it to 
remove excess water.  By 1981, 24 liverwort species were 
known to have potential allergenic sesquiterpene lactones 
(Asakawa 1981).  These compounds undoubtedly endow 
the same advantage to bryophytes that they do to flowering 
plants – discouraging consumption by hungry herbivores.   
 
 
 
Figure 98.  Frullania tamarisci, showing underside of 
branch with lobules by which the genus may be determined.  
Photo by Michael Lüth, with permission. 
 
Frullania tamarisci (Figure 43, Figure 98) grows on 
trees and can cause skin irritations for loggers and even for 
their wives who handle their clothes.  Allergic reactions to 
Frullania nisquallensis (Figure 99) occurred in patch tests 
on seven forest workers who had contact dermatitis 
(Mitchell et al. 1969).  These forest workers exhibited the 
dermatitis only when they were working on forest areas.  
The problem was worse in wet weather and appeared 
within 1-2 days of starting work.  The condition persisted 
for 2-4 weeks after leaving work in forested areas where 
the liverwort grew.  The condition is often known locally in 
British Columbia, Canada, as cedar poisoning, but in fact it 
is caused by the liverworts that commonly grow on the 
cedars (Thuja; Figure 100). 
 
 
Figure 99.  Frullania nisquallensis, a leafy liverwort 
epiphyte that causes allergic reactions among forest workers.  
Photo by Dale Vitt, with permission. 
 
Figure 100.  Thuja plicata, host plant for Frullania species.  
Photo from <www.nwplants.com>, through Creative Commons. 
  
Summary 
Bryophytes, especially liverworts, often have 
distinct odors, suggesting aromatic compounds such as 
phenols.  However, few bryophytes have been linked to 
actual curative properties and identifiable associated 
compounds. 
One danger in using bryophytes is that the same 
compounds that may have antibiotic properties may 
also be toxic or allergenic, or be associated with such 
compounds.  Furthermore, peatland mosses may have 
associated fungi that cause sporotrichosis. 
Many antibiotics have been isolated from 
bryophytes, but few have been developed for medical 
use, despite their demonstrated effectiveness.  In 
Germany, Ceratodon purpureus and Bryum 
argenteum are used to cure fungal infections of horses.  
Several medical uses seem promising, such as 
antileukemic properties and anticancer agents. 
The most promising uses of bryophytes in 
medicine seem to lie in genetic engineering.  
Bryophytes are being used already to produce human 
blood-clotting proteins, while others are known to 
reduce thrombin activity.  
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